DOClass,Disease,DiseaseClass,EvidenceIndexGDA,EvidenceLevelGDA,FirstRef,Gene,GeneDPI,GeneDSI,GeneFullName,GenePLI,HPOClass,LastRef,NumDiseasesAssociatedToGene,NumGenesDisease,NumPMIDs,NumVariantsAssociatedToGene,NumVariantsDisease,NumVariantsGDA,PathwayIDs,PathwayNames,ProteinClass,ScoreGDA,SemanticType,Type,UnitProt,diseaseUMLSCUI,geneEnsemblIDs,geneNcbiID,geneNcbiType,numCTs,numberChemsIncludedInEvidence,numberPmidsWithChemsIncludedInEvidence
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.898042414355628,,1979.0,AGT,0.96,0.34,angiotensinogen,1.6654e-08,Abnormality of the cardiovascular system (01626),2020.0,108,301,85,74,371,0,"R-HSA-1430728,R-HSA-162582,R-HSA-392499","Metabolism,Signal Transduction,Metabolism of proteins",Enzyme modulator,1.0,Disease or Syndrome (T047),disease,"B0ZBE2,P01019,B2R5S1",C0020538,ENSG00000135744,183,protein-coding,45,22,26
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8859504132231405,,1975.0,REN,0.96,0.38,renin,1.7791e-12,Abnormality of the cardiovascular system (01626),2011.0,42,301,18,39,371,0,R-HSA-392499,Metabolism of proteins,Enzyme,1.0,Disease or Syndrome (T047),disease,P00797,C0020538,ENSG00000143839,5972,protein-coding,90,6,6
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8549222797927462,,1993.0,EDN1,0.96,0.35,endothelin 1,0.0044888,Abnormality of the cardiovascular system (01626),2006.0,74,301,14,9,371,0,"R-HSA-1266738,R-HSA-162582","Developmental Biology,Signal Transduction",Signaling,1.0,Disease or Syndrome (T047),disease,"P05305,Q6FH53",C0020538,ENSG00000078401,1906,protein-coding,18,6,5
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9158878504672896,,1989.0,NPPA,0.91,0.42,natriuretic peptide A,0.0013161,Abnormality of the cardiovascular system (01626),2020.0,57,301,8,59,371,0,"R-HSA-392499,R-HSA-397014,R-HSA-74160","Metabolism of proteins,Muscle contraction,Gene expression (Transcription)",,1.0,Disease or Syndrome (T047),disease,P01160,C0020538,ENSG00000175206,4878,protein-coding,4,2,2
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9379310344827586,,2002.0,ACE2,0.96,0.41,angiotensin converting enzyme 2,,Abnormality of the cardiovascular system (01626),2011.0,24,301,7,3,371,0,"R-HSA-1643685,R-HSA-392499","Disease,Metabolism of proteins",Enzyme,1.0,Disease or Syndrome (T047),disease,Q9BYF1,C0020538,ENSG00000130234,59272,protein-coding,3,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.847457627118644,,2008.0,TNF,0.96,0.23,tumor necrosis factor,0.85687,Abnormality of the cardiovascular system (01626),2020.0,308,301,5,9,371,0,"R-HSA-1266738,R-HSA-162582,R-HSA-168256","Developmental Biology,Signal Transduction,Immune System",Signaling,1.0,Disease or Syndrome (T047),disease,"P01375,Q5STB3",C0020538,ENSG00000232810,7124,protein-coding,30,5,4
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8230088495575221,,2016.0,IL6,0.96,0.23,interleukin 6,0.19935,Abnormality of the cardiovascular system (01626),2020.0,209,301,5,5,371,0,"R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-392499,R-HSA-74160,R-HSA-8953897","Signal Transduction,Disease,Immune System,Metabolism of proteins,Gene expression (Transcription),Cellular responses to stimuli",,1.0,Disease or Syndrome (T047),disease,"B4DVM1,P05231,B5MC21,B4DNQ5,Q75MH2",C0020538,ENSG00000136244,3569,protein-coding,41,3,3
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.7399103139013453,,2001.0,NOS3,1.0,0.36,nitric oxide synthase 3,2.4053e-25,Abnormality of the cardiovascular system (01626),2009.0,125,301,5,14,371,1,"R-HSA-109582,R-HSA-1430728,R-HSA-162582,R-HSA-168256","Hemostasis,Metabolism,Signal Transduction,Immune System",,1.0,Disease or Syndrome (T047),disease,"A0S0A6,P29474",C0020538,ENSG00000164867,4846,protein-coding,3,2,2
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8735177865612648,,1996.0,AGTR1,0.91,0.41,angiotensin II receptor type 1,7.1609e-05,Abnormality of the cardiovascular system (01626),2016.0,38,301,4,53,371,0,"R-HSA-162582,R-HSA-5653656","Signal Transduction,Vesicle-mediated transport",G-protein coupled receptor,1.0,Disease or Syndrome (T047),disease,"D3DNG8,P30556,Q53YY0,A0A0A0MSE3,Q6NUP5",C0020538,ENSG00000144891,185,protein-coding,1,3,2
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8511904761904762,,2002.0,LEP,0.96,0.31,leptin,0.0070036,Abnormality of the cardiovascular system (01626),2016.0,59,301,4,66,371,0,"R-HSA-1266738,R-HSA-162582,R-HSA-392499","Developmental Biology,Signal Transduction,Metabolism of proteins",,1.0,Disease or Syndrome (T047),disease,"A4D0Y8,P41159",C0020538,ENSG00000174697,3952,protein-coding,13,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8362573099415205,,2005.0,ACE,0.96,0.31,angiotensin I converting enzyme,5.7955e-32,Abnormality of the cardiovascular system (01626),2017.0,123,301,4,159,371,0,R-HSA-392499,Metabolism of proteins,Enzyme,1.0,Disease or Syndrome (T047),disease,"P12821,B4DKH4",C0020538,ENSG00000159640,1636,protein-coding,28,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8430851063829787,,2003.0,CRP,1.0,0.25,C-reactive protein,0.0005414,Abnormality of the cardiovascular system (01626),2010.0,63,301,4,1,371,0,R-HSA-168256,Immune System,,1.0,Disease or Syndrome (T047),disease,P02741,C0020538,ENSG00000132693,1401,protein-coding,104,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8669527896995708,,1998.0,INS,0.96,0.25,insulin,0.019763,Abnormality of the cardiovascular system (01626),2018.0,95,301,3,62,371,0,"R-HSA-1266738,R-HSA-1430728,R-HSA-162582,R-HSA-392499,R-HSA-5653656,R-HSA-74160","Developmental Biology,Metabolism,Signal Transduction,Metabolism of proteins,Vesicle-mediated transport,Gene expression (Transcription)",,1.0,Disease or Syndrome (T047),disease,"P01308,I3WAC9",C0020538,ENSG00000254647,3630,protein-coding,121,2,2
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9047619047619048,,2009.0,MMP2,0.91,0.32,matrix metallopeptidase 2,6.2654e-05,Abnormality of the cardiovascular system (01626),2009.0,73,301,1,80,371,0,"R-HSA-1266738,R-HSA-1474244,R-HSA-162582,R-HSA-168256,R-HSA-392499","Developmental Biology,Extracellular matrix organization,Signal Transduction,Immune System,Metabolism of proteins",Enzyme,1.0,Disease or Syndrome (T047),disease,P08253,C0020538,ENSG00000087245,4313,protein-coding,3,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9447852760736196,,,VEGFA,0.96,0.25,vascular endothelial growth factor A,0.1881,Abnormality of the cardiovascular system (01626),,109,301,0,6,371,0,"R-HSA-109582,R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-74160,R-HSA-8953897","Hemostasis,Signal Transduction,Disease,Immune System,Gene expression (Transcription),Cellular responses to stimuli",Signaling,1.0,Disease or Syndrome (T047),disease,"A0A0Y0IMM4,P15692,A2A2V4",C0020538,ENSG00000112715,7422,protein-coding,12,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8872180451127819,,,CYP11B2,0.74,0.51,cytochrome P450 family 11 subfamily B member 2,1.3398e-10,Abnormality of the cardiovascular system (01626),,17,301,0,100,371,3,"R-HSA-1430728,R-HSA-1643685","Metabolism,Disease",,1.0,Disease or Syndrome (T047),disease,P19099,C0020538,ENSG00000179142,1585,protein-coding,2,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.95,,1997.0,NPPB,0.91,0.39,natriuretic peptide B,1.8925e-05,Abnormality of the cardiovascular system (01626),2020.0,41,301,5,1,371,0,,,,0.95,Disease or Syndrome (T047),disease,P16860,C0020538,ENSG00000120937,4879,protein-coding,82,6,4
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9090909090909092,,1998.0,HSD11B1,0.96,0.49,hydroxysteroid 11-beta dehydrogenase 1,0.0022053,Abnormality of the cardiovascular system (01626),2011.0,16,301,3,5,371,0,"R-HSA-1430728,R-HSA-9748784","Metabolism,Drug ADME",,0.95,Disease or Syndrome (T047),disease,"P28845,X5D2L1",C0020538,ENSG00000117594,3290,protein-coding,1,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2002.0,SOD2,1.0,0.35,superoxide dismutase 2,0.032187,Abnormality of the cardiovascular system (01626),2014.0,192,301,3,5,371,0,"R-HSA-1643685,R-HSA-168256,R-HSA-1852241,R-HSA-74160,R-HSA-8953897","Disease,Immune System,Organelle biogenesis and maintenance,Gene expression (Transcription),Cellular responses to stimuli",Enzyme,0.95,Disease or Syndrome (T047),disease,"P04179,A0A384NL29,Q9UG59,Q96AM7,G5E9P6",C0020538,ENSG00000291237,6648,protein-coding,2,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.85,,1997.0,SOD1,1.0,0.33,superoxide dismutase 1,0.011954,Abnormality of the cardiovascular system (01626),2020.0,90,301,3,133,371,0,"R-HSA-109582,R-HSA-168256,R-HSA-8953897","Hemostasis,Immune System,Cellular responses to stimuli",Enzyme,0.95,Disease or Syndrome (T047),disease,"P00441,V9HWC9",C0020538,ENSG00000142168,6647,protein-coding,3,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8345323741007195,,2010.0,APOE,0.96,0.33,apolipoprotein E,0.00025529,Abnormality of the cardiovascular system (01626),2012.0,100,301,2,33,371,0,"R-HSA-1430728,R-HSA-162582,R-HSA-382551,R-HSA-392499,R-HSA-5653656,R-HSA-74160,R-HSA-9709957","Metabolism,Signal Transduction,Transport of small molecules,Metabolism of proteins,Vesicle-mediated transport,Gene expression (Transcription),Sensory Perception",,0.95,Disease or Syndrome (T047),disease,"A0A0S2Z3D5,P02649",C0020538,ENSG00000130203,348,protein-coding,1,2,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9230769230769232,,1997.0,ADRB1,0.91,0.49,adrenoceptor beta 1,0.1116,Abnormality of the cardiovascular system (01626),2000.0,25,301,2,3,371,0,R-HSA-162582,Signal Transduction,G-protein coupled receptor,0.95,Disease or Syndrome (T047),disease,P08588,C0020538,ENSG00000043591,153,protein-coding,3,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8444444444444444,,2005.0,ADD1,0.78,0.58,adducin 1,1.0,Abnormality of the cardiovascular system (01626),2009.0,10,301,2,10,371,0,"R-HSA-382551,R-HSA-5357801,R-HSA-8953897","Transport of small molecules,Programmed Cell Death,Cellular responses to stimuli",Cellular structure,0.95,Disease or Syndrome (T047),disease,"P35611,A0A804HL01",C0020538,ENSG00000087274,118,protein-coding,2,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8679245283018868,,2008.0,APOA1,0.91,0.37,apolipoprotein A1,5.2702e-07,Abnormality of the cardiovascular system (01626),2008.0,44,301,1,40,371,0,"R-HSA-109582,R-HSA-1430728,R-HSA-1643685,R-HSA-382551,R-HSA-392499,R-HSA-5653656,R-HSA-8953897,R-HSA-9709957","Hemostasis,Metabolism,Disease,Transport of small molecules,Metabolism of proteins,Vesicle-mediated transport,Cellular responses to stimuli,Sensory Perception",,0.95,Disease or Syndrome (T047),disease,"P02647,A0A024R3E3",C0020538,ENSG00000118137,335,protein-coding,6,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.875,,1989.0,ALB,0.96,0.28,albumin,0.10648,Abnormality of the cardiovascular system (01626),1989.0,88,301,1,45,371,0,"R-HSA-109582,R-HSA-1430728,R-HSA-382551,R-HSA-392499,R-HSA-5653656,R-HSA-8953897,R-HSA-9748784","Hemostasis,Metabolism,Transport of small molecules,Metabolism of proteins,Vesicle-mediated transport,Cellular responses to stimuli,Drug ADME",Transporter,0.95,Disease or Syndrome (T047),disease,P02768,C0020538,ENSG00000163631,213,protein-coding,81,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8466257668711656,,2003.0,ADIPOQ,0.96,0.33,"adiponectin, C1Q and collagen domain containing",3.5736e-09,Abnormality of the cardiovascular system (01626),2003.0,43,301,1,3,371,0,"R-HSA-1266738,R-HSA-1430728","Developmental Biology,Metabolism",,0.95,Disease or Syndrome (T047),disease,"B2R773,A8K660,Q15848",C0020538,ENSG00000181092,9370,protein-coding,23,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.951219512195122,,2010.0,MMP9,0.96,0.29,matrix metallopeptidase 9,3.7082e-25,Abnormality of the cardiovascular system (01626),2010.0,107,301,1,38,371,0,"R-HSA-1266738,R-HSA-1474244,R-HSA-162582,R-HSA-168256","Developmental Biology,Extracellular matrix organization,Signal Transduction,Immune System",Enzyme,0.95,Disease or Syndrome (T047),disease,P14780,C0020538,ENSG00000100985,4318,protein-coding,3,2,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9555555555555556,,1995.0,HSD11B2,0.87,0.51,hydroxysteroid 11-beta dehydrogenase 2,3.3476e-07,Abnormality of the cardiovascular system (01626),2000.0,11,301,4,26,371,0,"R-HSA-1430728,R-HSA-9748784","Metabolism,Drug ADME",Enzyme,0.9,Disease or Syndrome (T047),disease,P80365,C0020538,ENSG00000176387,3291,protein-coding,0,2,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9142857142857144,,2006.0,HMOX1,0.96,0.34,heme oxygenase 1,3.3466e-07,Abnormality of the cardiovascular system (01626),2012.0,83,301,3,5,371,0,"R-HSA-1430728,R-HSA-1643685,R-HSA-168256,R-HSA-382551,R-HSA-8953897,R-HSA-9609507","Metabolism,Disease,Immune System,Transport of small molecules,Cellular responses to stimuli,Protein localization",,0.9,Disease or Syndrome (T047),disease,"P09601,Q6FH11",C0020538,ENSG00000100292,3162,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9318181818181818,,2004.0,PPARG,0.96,0.33,peroxisome proliferator activated receptor gamma,0.21172,Abnormality of the cardiovascular system (01626),2016.0,77,301,3,103,371,0,"R-HSA-1266738,R-HSA-1430728,R-HSA-162582,R-HSA-392499,R-HSA-74160","Developmental Biology,Metabolism,Signal Transduction,Metabolism of proteins,Gene expression (Transcription)",Nuclear receptor,0.9,Disease or Syndrome (T047),disease,"P37231,A0A494C1F9,E9PFX5,D2KUA6,E9PFV2",C0020538,ENSG00000132170,5468,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8125,,2012.0,WNK4,0.65,0.65,WNK lysine deficient protein kinase 4,3.9577000000000004e-25,Abnormality of the cardiovascular system (01626),2012.0,5,301,1,42,371,0,R-HSA-382551,Transport of small molecules,Kinase,0.9,Disease or Syndrome (T047),disease,Q96J92,C0020538,ENSG00000126562,65266,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8,,2012.0,WNK1,0.83,0.51,WNK lysine deficient protein kinase 1,1.0,Abnormality of the cardiovascular system (01626),2012.0,19,301,1,659,371,0,R-HSA-382551,Transport of small molecules,Kinase,0.9,Disease or Syndrome (T047),disease,"Q9H4A3,A5D8Z4,F5GWT4",C0020538,ENSG00000060237,65125,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9285714285714286,,2003.0,ECE1,0.83,0.51,endothelin converting enzyme 1,0.98713,Abnormality of the cardiovascular system (01626),2003.0,13,301,1,16,371,0,R-HSA-162582,Signal Transduction,Enzyme,0.9,Disease or Syndrome (T047),disease,P42892,C0020538,ENSG00000117298,1889,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9,,,CORIN,0.65,0.59,"corin, serine peptidase",2.1526e-25,Abnormality of the cardiovascular system (01626),,8,301,0,6,371,1,R-HSA-397014,Muscle contraction,,0.9,Disease or Syndrome (T047),disease,"A0A087X1D5,Q9Y5Q5,B4E1Y7,J3KR83,B4E2W9",C0020538,ENSG00000145244,10699,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.7222222222222222,,2016.0,IL1B,0.96,0.27,interleukin 1 beta,0.48761,Abnormality of the cardiovascular system (01626),2020.0,162,301,5,4,371,0,"R-HSA-1643685,R-HSA-168256,R-HSA-5357801","Disease,Immune System,Programmed Cell Death",,0.9,Disease or Syndrome (T047),disease,P01584,C0020538,ENSG00000125538,3553,protein-coding,10,3,3
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8909090909090909,,1984.0,AVP,0.96,0.36,arginine vasopressin,3.3806e-05,Abnormality of the cardiovascular system (01626),2009.0,43,301,5,24,371,0,"R-HSA-162582,R-HSA-1643685,R-HSA-382551,R-HSA-400253,R-HSA-5653656","Signal Transduction,Disease,Transport of small molecules,Circadian Clock,Vesicle-mediated transport",Signaling,0.9,Disease or Syndrome (T047),disease,"P01185,X5DQP6",C0020538,ENSG00000101200,551,protein-coding,6,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.875,,2001.0,CAT,1.0,0.35,catalase,1.6098e-08,Abnormality of the cardiovascular system (01626),2012.0,95,301,4,5,371,0,"R-HSA-168256,R-HSA-74160,R-HSA-8953897,R-HSA-9609507","Immune System,Gene expression (Transcription),Cellular responses to stimuli,Protein localization",Enzyme,0.9,Disease or Syndrome (T047),disease,"A0A384P5Q0,P04040",C0020538,ENSG00000121691,847,protein-coding,1,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9021739130434784,,2002.0,SCNN1A,0.91,0.5,sodium channel epithelial 1 subunit alpha,4.9869e-18,Abnormality of the cardiovascular system (01626),2013.0,26,301,2,85,371,0,"R-HSA-382551,R-HSA-9709957","Transport of small molecules,Sensory Perception",Ion channel,0.9,Disease or Syndrome (T047),disease,P37088,C0020538,ENSG00000111319,6337,protein-coding,1,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.6666666666666666,,2002.0,ICAM1,0.96,0.33,intercellular adhesion molecule 1,1.834e-06,Abnormality of the cardiovascular system (01626),2002.0,61,301,2,7,371,0,"R-HSA-1474244,R-HSA-168256","Extracellular matrix organization,Immune System",,0.9,Disease or Syndrome (T047),disease,"P05362,A0A384MEK5",C0020538,ENSG00000090339,3383,protein-coding,10,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8656716417910447,,2010.0,SERPINE1,0.96,0.34,serpin family E member 1,0.03418,Abnormality of the cardiovascular system (01626),2012.0,65,301,2,56,371,0,"R-HSA-109582,R-HSA-1474244,R-HSA-162582,R-HSA-400253,R-HSA-74160","Hemostasis,Extracellular matrix organization,Signal Transduction,Circadian Clock,Gene expression (Transcription)",Enzyme modulator,0.9,Disease or Syndrome (T047),disease,P05121,C0020538,ENSG00000106366,5054,protein-coding,13,2,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8888888888888888,,2001.0,TGFB1,0.91,0.26,transforming growth factor beta 1,0.025965,Abnormality of the cardiovascular system (01626),2009.0,136,301,2,37,371,0,"R-HSA-109582,R-HSA-1266738,R-HSA-1474244,R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-392499,R-HSA-74160","Hemostasis,Developmental Biology,Extracellular matrix organization,Signal Transduction,Disease,Immune System,Metabolism of proteins,Gene expression (Transcription)",Signaling,0.9,Disease or Syndrome (T047),disease,"P01137,A0A499FJK2",C0020538,ENSG00000105329,7040,protein-coding,2,2,2
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.96,,2002.0,VCAM1,0.96,0.38,vascular cell adhesion molecule 1,4.069e-09,Abnormality of the cardiovascular system (01626),2009.0,21,301,2,0,371,0,"R-HSA-1474244,R-HSA-168256","Extracellular matrix organization,Immune System",,0.9,Disease or Syndrome (T047),disease,P19320,C0020538,ENSG00000162692,7412,protein-coding,9,2,2
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.75,,2009.0,IGF1,0.96,0.28,insulin like growth factor 1,0.75878,Abnormality of the cardiovascular system (01626),2012.0,71,301,2,118,371,0,"R-HSA-109582,R-HSA-162582,R-HSA-392499","Hemostasis,Signal Transduction,Metabolism of proteins",,0.9,Disease or Syndrome (T047),disease,"Q59GC5,P05019,Q13429,Q5U743",C0020538,ENSG00000017427,3479,protein-coding,4,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9210526315789472,,2010.0,CCL2,0.96,0.31,C-C motif chemokine ligand 2,0.098507,Abnormality of the cardiovascular system (01626),2016.0,104,301,2,2,371,0,"R-HSA-162582,R-HSA-168256,R-HSA-8953897","Signal Transduction,Immune System,Cellular responses to stimuli",Signaling,0.9,Disease or Syndrome (T047),disease,P13500,C0020538,ENSG00000108691,6347,protein-coding,7,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.85,,2006.0,HP,0.96,0.36,haptoglobin,,Abnormality of the cardiovascular system (01626),2006.0,53,301,1,3,371,0,"R-HSA-168256,R-HSA-5653656","Immune System,Vesicle-mediated transport",,0.9,Disease or Syndrome (T047),disease,"P00738,Q6PEJ8,A0A0C4DGL8",C0020538,ENSG00000257017,3240,protein-coding,2,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9272727272727272,,2012.0,UMOD,0.96,0.49,uromodulin,8.6769e-23,Abnormality of the cardiovascular system (01626),2012.0,9,301,1,106,371,1,R-HSA-392499,Metabolism of proteins,,0.9,Disease or Syndrome (T047),disease,P07911,C0020538,ENSG00000169344,7369,protein-coding,1,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8478260869565217,,1991.0,PTH,0.91,0.35,parathyroid hormone,0.047072,Abnormality of the cardiovascular system (01626),1991.0,27,301,1,10,371,0,R-HSA-162582,Signal Transduction,,0.9,Disease or Syndrome (T047),disease,P01270,C0020538,ENSG00000152266,5741,protein-coding,2,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9,,2010.0,TIMP1,0.91,0.36,TIMP metallopeptidase inhibitor 1,,Abnormality of the cardiovascular system (01626),2010.0,27,301,1,0,371,0,"R-HSA-109582,R-HSA-1474244,R-HSA-162582,R-HSA-168256,R-HSA-392499","Hemostasis,Extracellular matrix organization,Signal Transduction,Immune System,Metabolism of proteins",Enzyme modulator,0.9,Disease or Syndrome (T047),disease,"P01033,Q6FGX5",C0020538,ENSG00000102265,7076,protein-coding,1,2,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9318181818181818,,,CHGA,0.96,0.4,chromogranin A,5.9758e-12,Abnormality of the cardiovascular system (01626),,11,301,0,7,371,0,R-HSA-168256,Immune System,,0.9,Disease or Syndrome (T047),disease,"P10645,Q86T07,G5E968",C0020538,ENSG00000100604,1113,protein-coding,2,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9444444444444444,,,XDH,0.91,0.47,xanthine dehydrogenase,5.404e-40,Abnormality of the cardiovascular system (01626),,39,301,0,244,371,0,"R-HSA-1430728,R-HSA-168256,R-HSA-9748784","Metabolism,Immune System,Drug ADME",Enzyme,0.9,Disease or Syndrome (T047),disease,P47989,C0020538,ENSG00000158125,7498,protein-coding,1,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9545454545454546,,,NPY,0.96,0.41,neuropeptide Y,0.0015886,Abnormality of the cardiovascular system (01626),,40,301,0,0,371,0,"R-HSA-162582,R-HSA-74160","Signal Transduction,Gene expression (Transcription)",Signaling,0.9,Disease or Syndrome (T047),disease,"A4D158,P01303",C0020538,ENSG00000122585,4852,protein-coding,2,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9047619047619048,,,RNLS,0.65,0.56,"renalase, FAD dependent amine oxidase",3.3258e-10,Abnormality of the cardiovascular system (01626),,4,301,0,26,371,0,R-HSA-1430728,Metabolism,,0.9,Disease or Syndrome (T047),disease,"Q5VYX0,B4DJW3",C0020538,ENSG00000184719,55328,protein-coding,2,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8421052631578947,,,RETN,0.96,0.4,resistin,0.0043156,Abnormality of the cardiovascular system (01626),,12,301,0,1,371,0,"R-HSA-168256,R-HSA-74160","Immune System,Gene expression (Transcription)",,0.9,Disease or Syndrome (T047),disease,Q9HD89,C0020538,ENSG00000104918,56729,protein-coding,3,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8648648648648649,,,ADRB2,0.96,0.42,adrenoceptor beta 2,0.0010085,Abnormality of the cardiovascular system (01626),,49,301,0,3,371,0,"R-HSA-162582,R-HSA-392499,R-HSA-5653656","Signal Transduction,Metabolism of proteins,Vesicle-mediated transport",G-protein coupled receptor,0.9,Disease or Syndrome (T047),disease,"P07550,X5DQM5",C0020538,ENSG00000169252,154,protein-coding,1,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8620689655172413,,2006.0,CYBA,0.87,0.49,cytochrome b-245 alpha chain,2.5483e-10,Abnormality of the cardiovascular system (01626),2020.0,20,301,4,130,371,0,"R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-8953897","Signal Transduction,Disease,Immune System,Cellular responses to stimuli",,0.85,Disease or Syndrome (T047),disease,"B4DT46,P13498,H3BNP7",C0020538,ENSG00000051523,1535,protein-coding,0,2,2
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9333333333333332,,2008.0,NOS2,1.0,0.33,nitric oxide synthase 2,1.9485999999999999e-22,Abnormality of the cardiovascular system (01626),2016.0,85,301,3,12,371,0,"R-HSA-109582,R-HSA-1643685,R-HSA-168256,R-HSA-9609507","Hemostasis,Disease,Immune System,Protein localization",,0.85,Disease or Syndrome (T047),disease,P35228,C0020538,ENSG00000007171,4843,protein-coding,0,3,2
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9285714285714286,,2016.0,TH,0.91,0.45,tyrosine hydroxylase,,Abnormality of the cardiovascular system (01626),2020.0,32,301,3,329,371,0,R-HSA-1430728,Metabolism,,0.85,Disease or Syndrome (T047),disease,"P07101,P78428",C0020538,ENSG00000180176,7054,protein-coding,0,2,2
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.7741935483870968,,2008.0,NR3C1,0.96,0.37,nuclear receptor subfamily 3 group C member 1,1.0,Abnormality of the cardiovascular system (01626),2010.0,41,301,2,116,371,0,"R-HSA-162582,R-HSA-1643685,R-HSA-392499,R-HSA-400253,R-HSA-74160,R-HSA-8953897","Signal Transduction,Disease,Metabolism of proteins,Circadian Clock,Gene expression (Transcription),Cellular responses to stimuli",Nuclear receptor,0.85,Disease or Syndrome (T047),disease,"E5KQF6,P04150,E5KQF5,F1D8N4",C0020538,ENSG00000113580,2908,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.75,,2012.0,LEPR,0.96,0.41,leptin receptor,8.8607e-05,Abnormality of the cardiovascular system (01626),2012.0,67,301,1,98,371,0,R-HSA-162582,Signal Transduction,Signaling,0.85,Disease or Syndrome (T047),disease,"P48357,Q4G138",C0020538,ENSG00000116678,3953,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9473684210526316,,2009.0,ATP2B1,0.83,0.57,ATPase plasma membrane Ca2+ transporting 1,1.0,Abnormality of the cardiovascular system (01626),2009.0,16,301,1,44,371,9,"R-HSA-109582,R-HSA-382551,R-HSA-397014,R-HSA-9709957","Hemostasis,Transport of small molecules,Muscle contraction,Sensory Perception",Transporter,0.85,Disease or Syndrome (T047),disease,P20020,C0020538,ENSG00000070961,490,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9523809523809524,,2003.0,EDNRA,0.91,0.44,endothelin receptor type A,0.99906,Abnormality of the cardiovascular system (01626),2003.0,19,301,1,12,371,0,R-HSA-162582,Signal Transduction,G-protein coupled receptor,0.85,Disease or Syndrome (T047),disease,P25101,C0020538,ENSG00000151617,1909,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9285714285714286,,2006.0,UCP2,0.91,0.47,uncoupling protein 2,1.1875e-08,Abnormality of the cardiovascular system (01626),2006.0,20,301,1,3,371,0,R-HSA-1430728,Metabolism,Transporter,0.85,Disease or Syndrome (T047),disease,P55851,C0020538,ENSG00000175567,7351,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8571428571428571,,2012.0,GSTT1,0.96,0.39,glutathione S-transferase theta 1,,Abnormality of the cardiovascular system (01626),2012.0,145,301,1,0,371,0,"R-HSA-1430728,R-HSA-9748784","Metabolism,Drug ADME",,0.85,Disease or Syndrome (T047),disease,"A0A0G2JRQ5,P30711,Q4GZS9,Q4W251,A0A0G2JRN4",C0020538,,2952,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2003.0,KLK1,0.87,0.51,kallikrein 1,8.3143e-07,Abnormality of the cardiovascular system (01626),2003.0,14,301,1,1,371,0,R-HSA-392499,Metabolism of proteins,Enzyme,0.85,Disease or Syndrome (T047),disease,"A0A1R3UCD2,P06870",C0020538,ENSG00000167748,3816,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.875,,1999.0,BDKRB2,0.87,0.5,bradykinin receptor B2,8.0397e-05,Abnormality of the cardiovascular system (01626),1999.0,28,301,1,1,371,0,R-HSA-162582,Signal Transduction,G-protein coupled receptor,0.85,Disease or Syndrome (T047),disease,P30411,C0020538,ENSG00000168398,624,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8181818181818182,,1998.0,GNAS,0.96,0.38,GNAS complex locus,0.99999,Abnormality of the cardiovascular system (01626),1998.0,65,301,1,130,371,0,"R-HSA-109582,R-HSA-1430728,R-HSA-162582,R-HSA-1643685,R-HSA-382551","Hemostasis,Metabolism,Signal Transduction,Disease,Transport of small molecules",Enzyme modulator,0.85,Disease or Syndrome (T047),disease,"B0AZR9,A0A0S2Z3S5,A0A7I2V5R6,Q5JWF2,P63092,A0A590UJF0,P84996,A0A0S2Z3H8,Q14455,Q5FWY2,Q5JWD1,O95467",C0020538,ENSG00000087460,2778,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.75,,,CLCNKB,0.78,0.55,chloride voltage-gated channel Kb,1.4014999999999998e-22,Abnormality of the cardiovascular system (01626),,12,301,0,50,371,0,R-HSA-382551,Transport of small molecules,Ion channel,0.85,Disease or Syndrome (T047),disease,"P51801,A8K8H0",C0020538,ENSG00000184908,1188,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,NPR3,0.78,0.54,natriuretic peptide receptor 3,1.2655e-05,Abnormality of the cardiovascular system (01626),,4,301,0,37,371,1,,,,0.85,Disease or Syndrome (T047),disease,"P17342,A8K4A5,Q60I31",C0020538,ENSG00000113389,4883,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8888888888888888,,,ALDH2,0.96,0.43,aldehyde dehydrogenase 2 family member,5.8061e-11,Abnormality of the cardiovascular system (01626),,49,301,0,9,371,1,"R-HSA-112316,R-HSA-1430728,R-HSA-392499,R-HSA-397014","Neuronal System,Metabolism,Metabolism of proteins,Muscle contraction",Enzyme,0.85,Disease or Syndrome (T047),disease,"P05091,A0A384NPN7",C0020538,ENSG00000111275,217,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8660714285714286,,1974.0,POMC,0.96,0.32,proopiomelanocortin,3.3396e-10,Abnormality of the cardiovascular system (01626),2010.0,115,301,68,40,371,0,"R-HSA-1266738,R-HSA-1430728,R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-392499,R-HSA-74160","Developmental Biology,Metabolism,Signal Transduction,Disease,Immune System,Metabolism of proteins,Gene expression (Transcription)",,0.85,Disease or Syndrome (T047),disease,P01189,C0020538,ENSG00000115138,5443,protein-coding,5,22,26
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.7924528301886793,,1992.0,EPO,0.96,0.34,erythropoietin,0.02674,Abnormality of the cardiovascular system (01626),2000.0,78,301,2,9,371,0,"R-HSA-162582,R-HSA-8953897","Signal Transduction,Cellular responses to stimuli",,0.85,Disease or Syndrome (T047),disease,"P01588,G9JKG7",C0020538,ENSG00000130427,2056,protein-coding,6,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9130434782608696,,1991.0,CALCA,0.96,0.33,calcitonin related polypeptide alpha,0.13456,Abnormality of the cardiovascular system (01626),1999.0,22,301,2,0,371,0,"R-HSA-162582,R-HSA-392499","Signal Transduction,Metabolism of proteins",Signaling,0.85,Disease or Syndrome (T047),disease,"P01258,P06881",C0020538,ENSG00000110680,796,protein-coding,2,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.7777777777777778,,2012.0,GCG,0.96,0.35,glucagon,0.13736,Abnormality of the cardiovascular system (01626),2012.0,32,301,1,1,371,0,"R-HSA-1430728,R-HSA-162582,R-HSA-392499","Metabolism,Signal Transduction,Metabolism of proteins",,0.85,Disease or Syndrome (T047),disease,P01275,C0020538,ENSG00000115263,2641,protein-coding,8,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9444444444444444,,2004.0,SELP,0.96,0.41,selectin P,4.649199999999999e-21,Abnormality of the cardiovascular system (01626),2004.0,15,301,1,6,371,0,R-HSA-109582,Hemostasis,,0.85,Disease or Syndrome (T047),disease,"Q5R341,Q6NUL9,P16109",C0020538,ENSG00000174175,6403,protein-coding,6,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9090909090909092,,2008.0,SLC12A3,0.87,0.48,solute carrier family 12 member 3,4.595299999999999e-28,Abnormality of the cardiovascular system (01626),2008.0,15,301,1,392,371,0,"R-HSA-1643685,R-HSA-382551","Disease,Transport of small molecules",Transporter,0.85,Disease or Syndrome (T047),disease,P55017,C0020538,ENSG00000070915,6559,protein-coding,2,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.945945945945946,,2001.0,VDR,0.96,0.34,vitamin D receptor,0.0107,Abnormality of the cardiovascular system (01626),2001.0,72,301,1,151,371,0,"R-HSA-1430728,R-HSA-392499,R-HSA-74160","Metabolism,Metabolism of proteins,Gene expression (Transcription)",Nuclear receptor,0.85,Disease or Syndrome (T047),disease,"P11473,F1D8P8",C0020538,ENSG00000111424,7421,protein-coding,1,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9411764705882352,,2020.0,NFE2L2,0.91,0.35,NFE2 like bZIP transcription factor 2,0.49709,Abnormality of the cardiovascular system (01626),2020.0,74,301,1,14,371,0,"R-HSA-1643685,R-HSA-392499,R-HSA-8953897","Disease,Metabolism of proteins,Cellular responses to stimuli",Enzyme,0.85,Disease or Syndrome (T047),disease,"A0A8V8TPA8,A0A8V8TN14,Q16236",C0020538,ENSG00000116044,4780,protein-coding,1,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9629629629629628,,1981.0,KNG1,0.96,0.43,kininogen 1,0.80958,Abnormality of the cardiovascular system (01626),1981.0,28,301,1,12,371,0,"R-HSA-109582,R-HSA-162582,R-HSA-392499","Hemostasis,Signal Transduction,Metabolism of proteins",Enzyme modulator,0.85,Disease or Syndrome (T047),disease,P01042,C0020538,ENSG00000113889,3827,protein-coding,6,2,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8846153846153846,,2004.0,PTGS2,0.96,0.32,prostaglandin-endoperoxide synthase 2,1.0,Abnormality of the cardiovascular system (01626),2012.0,143,301,4,1,371,0,"R-HSA-1430728,R-HSA-168256","Metabolism,Immune System",Enzyme,0.8,Disease or Syndrome (T047),disease,P35354,C0020538,ENSG00000073756,5743,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.95,,2016.0,NOX4,0.91,0.46,NADPH oxidase 4,1.5907e-07,Abnormality of the cardiovascular system (01626),2020.0,8,301,3,28,371,0,"R-HSA-1643685,R-HSA-8953897","Disease,Cellular responses to stimuli",Enzyme,0.8,Disease or Syndrome (T047),disease,"B7Z529,B7Z523,B3KQ17,Q9NPH5",C0020538,ENSG00000086991,50507,protein-coding,0,2,2
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.875,,2004.0,SCNN1B,0.83,0.57,sodium channel epithelial 1 subunit beta,1.4217e-09,Abnormality of the cardiovascular system (01626),2009.0,18,301,3,77,371,0,"R-HSA-382551,R-HSA-9709957","Transport of small molecules,Sensory Perception",Ion channel,0.8,Disease or Syndrome (T047),disease,"P51168,B2R812",C0020538,ENSG00000168447,6338,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8888888888888888,,2005.0,PPARA,0.91,0.39,peroxisome proliferator activated receptor alpha,0.0034658,Abnormality of the cardiovascular system (01626),2009.0,41,301,2,5,371,0,"R-HSA-1266738,R-HSA-1430728,R-HSA-1852241,R-HSA-392499,R-HSA-400253,R-HSA-74160,R-HSA-8953897","Developmental Biology,Metabolism,Organelle biogenesis and maintenance,Metabolism of proteins,Circadian Clock,Gene expression (Transcription),Cellular responses to stimuli",Nuclear receptor,0.8,Disease or Syndrome (T047),disease,"F1D8S4,Q07869",C0020538,ENSG00000186951,5465,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8857142857142857,,2005.0,GNB3,0.87,0.52,G protein subunit beta 3,3.7747e-09,Abnormality of the cardiovascular system (01626),2005.0,22,301,2,4,371,0,"R-HSA-109582,R-HSA-112316,R-HSA-1430728,R-HSA-162582,R-HSA-1643685,R-HSA-382551,R-HSA-392499,R-HSA-9709957","Hemostasis,Neuronal System,Metabolism,Signal Transduction,Disease,Transport of small molecules,Metabolism of proteins,Sensory Perception",Enzyme,0.8,Disease or Syndrome (T047),disease,"E9PCP0,F1T0G5,P16520",C0020538,ENSG00000111664,2784,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2002.0,FOS,0.91,0.36,"Fos proto-oncogene, AP-1 transcription factor subunit",0.8667,Abnormality of the cardiovascular system (01626),2013.0,31,301,2,1,371,0,"R-HSA-162582,R-HSA-168256,R-HSA-74160,R-HSA-8953897","Signal Transduction,Immune System,Gene expression (Transcription),Cellular responses to stimuli",Transcription factor,0.8,Disease or Syndrome (T047),disease,"Q6FG41,P01100",C0020538,ENSG00000170345,2353,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9333333333333332,,2006.0,SOD3,0.87,0.49,superoxide dismutase 3,1.9833e-05,Abnormality of the cardiovascular system (01626),2006.0,24,301,2,1,371,0,R-HSA-8953897,Cellular responses to stimuli,Enzyme,0.8,Disease or Syndrome (T047),disease,"A0A140VJU8,P08294",C0020538,ENSG00000109610,6649,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9565217391304348,,1991.0,RGS2,0.91,0.54,regulator of G protein signaling 2,2.0581e-05,Abnormality of the cardiovascular system (01626),1991.0,6,301,1,0,371,0,R-HSA-162582,Signal Transduction,Enzyme modulator,0.8,Disease or Syndrome (T047),disease,P41220,C0020538,ENSG00000116741,5997,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.90625,,2004.0,SCNN1G,0.91,0.53,sodium channel epithelial 1 subunit gamma,0.80584,Abnormality of the cardiovascular system (01626),2004.0,14,301,1,59,371,0,"R-HSA-382551,R-HSA-9709957","Transport of small molecules,Sensory Perception",Ion channel,0.8,Disease or Syndrome (T047),disease,"A5X2V1,P51170",C0020538,ENSG00000166828,6340,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.84375,,2012.0,LPL,0.87,0.43,lipoprotein lipase,3.0524e-12,Abnormality of the cardiovascular system (01626),2012.0,39,301,1,211,371,0,"R-HSA-1266738,R-HSA-1430728,R-HSA-382551,R-HSA-9709957","Developmental Biology,Metabolism,Transport of small molecules,Sensory Perception",Enzyme,0.8,Disease or Syndrome (T047),disease,"P06858,A0A1B1RVA9",C0020538,ENSG00000175445,4023,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8666666666666667,,2008.0,CD36,0.91,0.41,CD36 molecule (CD36 blood group),8.6824e-17,Abnormality of the cardiovascular system (01626),2008.0,25,301,1,116,371,0,"R-HSA-109582,R-HSA-1266738,R-HSA-1430728,R-HSA-1643685,R-HSA-168256,R-HSA-5653656","Hemostasis,Developmental Biology,Metabolism,Disease,Immune System,Vesicle-mediated transport",Receptor,0.8,Disease or Syndrome (T047),disease,"B7Z6C3,A4D1B1,P16671,E9PLT1",C0020538,ENSG00000135218,948,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2009.0,MTOR,0.96,0.29,mechanistic target of rapamycin kinase,1.0,Abnormality of the cardiovascular system (01626),2009.0,64,301,1,103,371,0,"R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-74160,R-HSA-8953897,R-HSA-9612973","Signal Transduction,Disease,Immune System,Gene expression (Transcription),Cellular responses to stimuli,Autophagy",Kinase,0.8,Disease or Syndrome (T047),disease,"P42345,A0A8V8TQ52",C0020538,ENSG00000198793,2475,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2006.0,ELN,0.87,0.39,elastin,7.2698e-10,Abnormality of the cardiovascular system (01626),2006.0,57,301,1,273,371,0,R-HSA-1474244,Extracellular matrix organization,,0.8,Disease or Syndrome (T047),disease,"Q8NBI4,Q6ZUN2,G3V0G6,B3KRT8,B4E3S4,E7ENM0,P15502,E7EN65,G5E950,Q59H17",C0020538,ENSG00000049540,2006,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9285714285714286,,2020.0,AGER,0.91,0.39,advanced glycosylation end-product specific receptor,2.5887e-14,Abnormality of the cardiovascular system (01626),2020.0,47,301,1,9,371,0,R-HSA-168256,Immune System,Receptor,0.8,Disease or Syndrome (T047),disease,"Q15109,B4DNX3,A0A1U9X785",C0020538,ENSG00000204305,177,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,HIF1A,0.96,0.32,hypoxia inducible factor 1 subunit alpha,0.99998,Abnormality of the cardiovascular system (01626),2012.0,56,301,1,2,371,0,"R-HSA-162582,R-HSA-168256,R-HSA-392499,R-HSA-400253,R-HSA-8953897","Signal Transduction,Immune System,Metabolism of proteins,Circadian Clock,Cellular responses to stimuli",Transcription factor,0.8,Disease or Syndrome (T047),disease,"Q16665,D0VY79",C0020538,ENSG00000100644,3091,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8666666666666667,,2010.0,NPR1,0.87,0.56,natriuretic peptide receptor 1,2.7513e-08,Abnormality of the cardiovascular system (01626),2010.0,9,301,1,2,371,0,R-HSA-397014,Muscle contraction,Kinase,0.8,Disease or Syndrome (T047),disease,"P16066,A0A140VJE6",C0020538,ENSG00000169418,4881,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2003.0,GCH1,0.91,0.49,GTP cyclohydrolase 1,0.3614,Abnormality of the cardiovascular system (01626),2003.0,39,301,1,193,371,0,R-HSA-1430728,Metabolism,Enzyme,0.8,Disease or Syndrome (T047),disease,"P30793,Q8IZH9",C0020538,ENSG00000131979,2643,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.96,,2005.0,UTS2,0.83,0.53,urotensin 2,0.002824,Abnormality of the cardiovascular system (01626),2005.0,7,301,1,6,371,0,R-HSA-162582,Signal Transduction,,0.8,Disease or Syndrome (T047),disease,"O95399,A0AVP6",C0020538,ENSG00000049247,10911,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2002.0,GRK2,0.91,0.49,G protein-coupled receptor kinase 2,1.0,Abnormality of the cardiovascular system (01626),2002.0,14,301,1,4,371,0,"R-HSA-162582,R-HSA-5653656","Signal Transduction,Vesicle-mediated transport",Kinase,0.8,Disease or Syndrome (T047),disease,"P25098,A0A0S2Z392",C0020538,ENSG00000173020,156,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9,,2005.0,AGTR2,0.87,0.47,angiotensin II receptor type 2,,Abnormality of the cardiovascular system (01626),2005.0,13,301,1,0,371,0,R-HSA-162582,Signal Transduction,G-protein coupled receptor,0.8,Disease or Syndrome (T047),disease,P50052,C0020538,ENSG00000180772,186,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9411764705882352,,2012.0,GLP1R,0.96,0.44,glucagon like peptide 1 receptor,0.98556,Abnormality of the cardiovascular system (01626),2012.0,3,301,1,12,371,0,"R-HSA-1430728,R-HSA-162582","Metabolism,Signal Transduction",G-protein coupled receptor,0.8,Disease or Syndrome (T047),disease,"A0A142FHB8,P43220",C0020538,ENSG00000112164,2740,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9285714285714286,,2012.0,OLR1,0.91,0.47,oxidized low density lipoprotein receptor 1,4.9309e-06,Abnormality of the cardiovascular system (01626),2012.0,20,301,1,2,371,0,"R-HSA-109582,R-HSA-168256","Hemostasis,Immune System",,0.8,Disease or Syndrome (T047),disease,P78380,C0020538,ENSG00000173391,4973,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.7,,,FTO,0.96,0.43,FTO alpha-ketoglutarate dependent dioxygenase,1.1171e-10,Abnormality of the cardiovascular system (01626),,32,301,0,226,371,0,R-HSA-73894,DNA Repair,,0.8,Disease or Syndrome (T047),disease,"B3KU60,A0A1B0GTC5,Q99770,Q9C0B1",C0020538,ENSG00000140718,79068,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8518518518518519,,,ADRB3,0.83,0.5,adrenoceptor beta 3,2.7754e-16,Abnormality of the cardiovascular system (01626),,23,301,0,3,371,0,R-HSA-162582,Signal Transduction,G-protein coupled receptor,0.8,Disease or Syndrome (T047),disease,"A8KAG8,P13945",C0020538,ENSG00000188778,155,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.75,,,HGF,0.91,0.35,hepatocyte growth factor,0.99616,Abnormality of the cardiovascular system (01626),,57,301,0,8,371,0,"R-HSA-109582,R-HSA-162582,R-HSA-1643685,R-HSA-168256","Hemostasis,Signal Transduction,Disease,Immune System",Enzyme,0.8,Disease or Syndrome (T047),disease,P14210,C0020538,ENSG00000019991,3082,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,SGK1,0.87,0.52,serum/glucocorticoid regulated kinase 1,0.0020197,Abnormality of the cardiovascular system (01626),,10,301,0,4,371,0,"R-HSA-162582,R-HSA-382551,R-HSA-74160","Signal Transduction,Transport of small molecules,Gene expression (Transcription)",Kinase,0.8,Disease or Syndrome (T047),disease,"B7Z325,E9PR89,O00141",C0020538,ENSG00000118515,6446,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,KDR,0.96,0.35,kinase insert domain receptor,1.0,Abnormality of the cardiovascular system (01626),,62,301,0,23,371,0,"R-HSA-1474244,R-HSA-162582,R-HSA-1643685","Extracellular matrix organization,Signal Transduction,Disease",Kinase,0.8,Disease or Syndrome (T047),disease,P35968,C0020538,ENSG00000128052,3791,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,ESR2,0.91,0.37,estrogen receptor 2,5.8401e-10,Abnormality of the cardiovascular system (01626),,49,301,0,15,371,0,"R-HSA-162582,R-HSA-1643685,R-HSA-74160","Signal Transduction,Disease,Gene expression (Transcription)",Nuclear receptor,0.8,Disease or Syndrome (T047),disease,"F1D8N3,Q7LCB3,Q92731,A0A348FV93,Q0PTK2",C0020538,ENSG00000140009,2100,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8181818181818182,,,PKD1,0.83,0.47,"polycystin 1, transient receptor potential channel interacting",1.0,Abnormality of the cardiovascular system (01626),,55,301,0,1377,371,4,R-HSA-1852241,Organelle biogenesis and maintenance,,0.8,Disease or Syndrome (T047),disease,P98161,C0020538,ENSG00000008710,5310,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,DRD1,0.91,0.49,dopamine receptor D1,0.99991,Abnormality of the cardiovascular system (01626),,20,301,0,1,371,0,R-HSA-162582,Signal Transduction,G-protein coupled receptor,0.8,Disease or Syndrome (T047),disease,P21728,C0020538,ENSG00000184845,1812,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,COMT,0.96,0.38,catechol-O-methyltransferase,0.00049511,Abnormality of the cardiovascular system (01626),,80,301,0,21,371,0,"R-HSA-112316,R-HSA-1430728,R-HSA-1643685","Neuronal System,Metabolism,Disease",Enzyme,0.8,Disease or Syndrome (T047),disease,"P21964,A0A140VJG8",C0020538,ENSG00000093010,1312,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8571428571428571,,,DBH,0.96,0.49,dopamine beta-hydroxylase,9.2071e-13,Abnormality of the cardiovascular system (01626),,22,301,0,162,371,0,R-HSA-1430728,Metabolism,,0.8,Disease or Syndrome (T047),disease,P09172,C0020538,ENSG00000123454,1621,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9655172413793104,,,EPHX2,0.83,0.49,epoxide hydrolase 2,4.6556e-22,Abnormality of the cardiovascular system (01626),,16,301,0,21,371,0,"R-HSA-1430728,R-HSA-9609507","Metabolism,Protein localization",Enzyme,0.8,Disease or Syndrome (T047),disease,P34913,C0020538,ENSG00000120915,2053,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2006.0,NCF1,0.91,0.47,neutrophil cytosolic factor 1,0.82043,Abnormality of the cardiovascular system (01626),2020.0,17,301,4,15,371,0,"R-HSA-162582,R-HSA-168256,R-HSA-8953897","Signal Transduction,Immune System,Cellular responses to stimuli",,0.8,Disease or Syndrome (T047),disease,P14598,C0020538,ENSG00000158517,653361,protein-coding,1,3,3
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.868421052631579,,2002.0,VWF,0.96,0.35,von Willebrand factor,4.5035000000000005e-27,Abnormality of the cardiovascular system (01626),2012.0,41,301,3,559,371,0,"R-HSA-109582,R-HSA-1474244,R-HSA-162582,R-HSA-1643685","Hemostasis,Extracellular matrix organization,Signal Transduction,Disease",Enzyme modulator,0.8,Disease or Syndrome (T047),disease,P04275,C0020538,ENSG00000110799,7450,protein-coding,8,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8333333333333334,,1999.0,AR,0.96,0.33,androgen receptor,,Abnormality of the cardiovascular system (01626),1999.0,42,301,1,242,371,0,"R-HSA-162582,R-HSA-392499,R-HSA-74160,R-HSA-8953897","Signal Transduction,Metabolism of proteins,Gene expression (Transcription),Cellular responses to stimuli",,0.8,Disease or Syndrome (T047),disease,"A0A087WUX9,F1D8N5,G4VV16,P10275,Q9NUA2",C0020538,ENSG00000169083,367,protein-coding,1,2,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.7619047619047619,,2012.0,PLAT,0.96,0.36,"plasminogen activator, tissue type",5.9432e-07,Abnormality of the cardiovascular system (01626),2012.0,92,301,1,6,371,0,"R-HSA-109582,R-HSA-162582","Hemostasis,Signal Transduction",Enzyme,0.8,Disease or Syndrome (T047),disease,"B4DN26,P00750",C0020538,ENSG00000104368,5327,protein-coding,4,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,ADD2,0.61,0.68,adducin 2,1.0,Abnormality of the cardiovascular system (01626),,2,301,0,0,371,0,R-HSA-382551,Transport of small molecules,Cellular structure,0.8,Disease or Syndrome (T047),disease,"P35612,Q05DK5",C0020538,ENSG00000075340,119,protein-coding,1,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,FABP3,0.91,0.45,fatty acid binding protein 3,0.027265,Abnormality of the cardiovascular system (01626),,4,301,0,0,371,0,R-HSA-1430728,Metabolism,,0.8,Disease or Syndrome (T047),disease,"P05413,A0A384MDY5",C0020538,ENSG00000121769,2170,protein-coding,2,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.75,,,NPPC,0.83,0.52,natriuretic peptide C,0.2199,Abnormality of the cardiovascular system (01626),,8,301,0,3,371,0,R-HSA-397014,Muscle contraction,Signaling,0.8,Disease or Syndrome (T047),disease,"P23582,E5LCN7",C0020538,ENSG00000163273,4880,protein-coding,2,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2001.0,FN1,0.91,0.35,fibronectin 1,1.0,Abnormality of the cardiovascular system (01626),2007.0,37,301,2,109,371,0,"R-HSA-109582,R-HSA-1474244,R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-392499","Hemostasis,Extracellular matrix organization,Signal Transduction,Disease,Immune System,Metabolism of proteins",Signaling,0.75,Disease or Syndrome (T047),disease,"Q9UQS6,P02751,Q6MZM7,Q6N084,Q6MZF4,B7ZLE5",C0020538,ENSG00000115414,2335,protein-coding,0,2,2
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.875,,2016.0,TLR4,0.96,0.32,toll like receptor 4,0.00040578,Abnormality of the cardiovascular system (01626),2020.0,87,301,2,4,371,0,"R-HSA-1643685,R-HSA-168256,R-HSA-5357801,R-HSA-8953897","Disease,Immune System,Programmed Cell Death,Cellular responses to stimuli",,0.75,Disease or Syndrome (T047),disease,O00206,C0020538,ENSG00000136869,7099,protein-coding,0,2,2
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9166666666666666,,2008.0,NEDD4L,0.87,0.5,NEDD4 like E3 ubiquitin protein ligase,0.99878,Abnormality of the cardiovascular system (01626),2013.0,11,301,2,78,371,0,"R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-382551,R-HSA-74160","Signal Transduction,Disease,Immune System,Transport of small molecules,Gene expression (Transcription)",Enzyme,0.75,Disease or Syndrome (T047),disease,"Q96PU5,B7Z2P9,B7Z6K0",C0020538,ENSG00000049759,23327,protein-coding,0,2,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8666666666666667,,2012.0,STK39,0.78,0.6,serine/threonine kinase 39,0.99999,Abnormality of the cardiovascular system (01626),2012.0,4,301,1,12,371,0,,,Kinase,0.75,Disease or Syndrome (T047),disease,Q9UEW8,C0020538,ENSG00000198648,27347,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2011.0,TACR1,0.91,0.45,tachykinin receptor 1,4.0199e-06,Abnormality of the cardiovascular system (01626),2011.0,16,301,1,1,371,0,"R-HSA-162582,R-HSA-5653656","Signal Transduction,Vesicle-mediated transport",G-protein coupled receptor,0.75,Disease or Syndrome (T047),disease,P25103,C0020538,ENSG00000115353,6869,protein-coding,1,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,1991.0,CAV1,0.91,0.38,caveolin 1,0.01393,Abnormality of the cardiovascular system (01626),1991.0,44,301,1,31,371,0,"R-HSA-109582,R-HSA-1430728,R-HSA-162582,R-HSA-1643685,R-HSA-74160","Hemostasis,Metabolism,Signal Transduction,Disease,Gene expression (Transcription)",Enzyme modulator,0.75,Disease or Syndrome (T047),disease,"Q2TNI1,Q7Z4F3,Q59E85,A9XTE5,Q03135",C0020538,ENSG00000105974,857,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.875,,2011.0,AHR,0.96,0.38,aryl hydrocarbon receptor,0.0077533,Abnormality of the cardiovascular system (01626),2011.0,74,301,1,1,371,0,R-HSA-1430728,Metabolism,Transcription factor,0.75,Disease or Syndrome (T047),disease,P35869,C0020538,ENSG00000106546,196,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9,,2001.0,DRD2,0.96,0.4,dopamine receptor D2,0.99986,Abnormality of the cardiovascular system (01626),2001.0,55,301,1,30,371,0,R-HSA-162582,Signal Transduction,G-protein coupled receptor,0.75,Disease or Syndrome (T047),disease,P14416,C0020538,ENSG00000149295,1813,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9444444444444444,,2018.0,FGF21,0.96,0.43,fibroblast growth factor 21,1.5619e-05,Abnormality of the cardiovascular system (01626),2018.0,13,301,1,1,371,0,R-HSA-382551,Transport of small molecules,Signaling,0.75,Disease or Syndrome (T047),disease,"Q9NSA1,A0A7U3L5M7",C0020538,ENSG00000105550,26291,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2000.0,ADRA2A,0.91,0.51,adrenoceptor alpha 2A,0.0045157,Abnormality of the cardiovascular system (01626),2000.0,20,301,1,0,371,0,"R-HSA-109582,R-HSA-1430728,R-HSA-162582,R-HSA-392499","Hemostasis,Metabolism,Signal Transduction,Metabolism of proteins",G-protein coupled receptor,0.75,Disease or Syndrome (T047),disease,P08913,C0020538,ENSG00000150594,150,protein-coding,0,2,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,CACNA1C,0.96,0.41,calcium voltage-gated channel subunit alpha1 C,1.0,Abnormality of the cardiovascular system (01626),2012.0,67,301,1,668,371,0,"R-HSA-1266738,R-HSA-1430728,R-HSA-397014","Developmental Biology,Metabolism,Muscle contraction",Ion channel,0.75,Disease or Syndrome (T047),disease,"A0A804HJB6,Q5V9X9,A0A0A0MSA1,Q59GU3,Q13936,A0A804HKC4,A0A804HI37,A0A0A0MR67,F5H522,A0A804HIJ8,E9PDI6",C0020538,ENSG00000151067,775,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9230769230769232,,2012.0,KCNJ1,0.83,0.56,potassium inwardly rectifying channel subfamily J member 1,3.2031e-09,Abnormality of the cardiovascular system (01626),2012.0,9,301,1,64,371,0,R-HSA-112316,Neuronal System,Ion channel,0.75,Disease or Syndrome (T047),disease,"A8K432,P48048",C0020538,ENSG00000151704,3758,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,1984.0,PLG,0.91,0.38,plasminogen,0.16223,Abnormality of the cardiovascular system (01626),1984.0,26,301,1,51,371,0,"R-HSA-109582,R-HSA-1474244,R-HSA-162582,R-HSA-392499","Hemostasis,Extracellular matrix organization,Signal Transduction,Metabolism of proteins",Enzyme,0.75,Disease or Syndrome (T047),disease,"Q5TEH5,P00747",C0020538,ENSG00000122194,5340,protein-coding,2,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,ABO,0.96,0.4,"ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase",,Abnormality of the cardiovascular system (01626),,36,301,0,55,371,0,R-HSA-1430728,Metabolism,Enzyme,0.75,Disease or Syndrome (T047),disease,"P16442,A0A089QDC1",C0020538,ENSG00000175164,28,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,GATA5,0.78,0.53,GATA binding protein 5,3.5589e-11,Abnormality of the cardiovascular system (01626),,32,301,0,21,371,0,R-HSA-109582,Hemostasis,,0.75,Disease or Syndrome (T047),disease,Q9BWX5,C0020538,ENSG00000130700,140628,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,CD14,0.96,0.38,CD14 molecule,0.0029347,Abnormality of the cardiovascular system (01626),,24,301,0,0,371,0,"R-HSA-1643685,R-HSA-168256,R-HSA-5357801","Disease,Immune System,Programmed Cell Death",,0.75,Disease or Syndrome (T047),disease,P08571,C0020538,ENSG00000170458,929,protein-coding,1,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,LOX,0.87,0.42,lysyl oxidase,0.97953,Abnormality of the cardiovascular system (01626),,32,301,0,37,371,0,R-HSA-1474244,Extracellular matrix organization,,0.75,Disease or Syndrome (T047),disease,"P28300,D0PNI2,B0AZT2,B7ZAJ4",C0020538,ENSG00000113083,4015,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,MYH9,0.83,0.47,myosin heavy chain 9,1.0,Abnormality of the cardiovascular system (01626),,43,301,0,269,371,1,"R-HSA-1266738,R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-5653656,R-HSA-9709957","Developmental Biology,Signal Transduction,Disease,Immune System,Vesicle-mediated transport,Sensory Perception",,0.75,Disease or Syndrome (T047),disease,P35579,C0020538,ENSG00000100345,4627,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.75,,,VHL,0.87,0.43,von Hippel-Lindau tumor suppressor,0.0019414,Abnormality of the cardiovascular system (01626),,55,301,0,822,371,0,"R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-392499,R-HSA-8953897","Signal Transduction,Disease,Immune System,Metabolism of proteins,Cellular responses to stimuli",Enzyme,0.75,Disease or Syndrome (T047),disease,"P40337,A0A024R2F2,A0A0S2Z4K1",C0020538,ENSG00000134086,7428,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.7777777777777778,,,PON1,1.0,0.41,paraoxonase 1,8.2563e-12,Abnormality of the cardiovascular system (01626),,95,301,0,5,371,0,"R-HSA-1430728,R-HSA-9748784","Metabolism,Drug ADME",,0.75,Disease or Syndrome (T047),disease,P27169,C0020538,ENSG00000005421,5444,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.9666666666666668,,,CYP4A11,0.48,0.66,cytochrome P450 family 4 subfamily A member 11,2.8465e-16,Abnormality of the cardiovascular system (01626),,1,301,0,0,371,0,R-HSA-1430728,Metabolism,Enzyme,0.75,Disease or Syndrome (T047),disease,Q02928,C0020538,ENSG00000187048,1579,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2020.0,HMGB1,0.96,0.36,high mobility group box 1,0.99972,Abnormality of the cardiovascular system (01626),2020.0,21,301,1,9,371,0,"R-HSA-1643685,R-HSA-168256,R-HSA-5357801","Disease,Immune System,Programmed Cell Death",Nucleic acid binding,0.7,Disease or Syndrome (T047),disease,P09429,C0020538,ENSG00000189403,3146,protein-coding,2,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8571428571428571,,,CYP2C9,0.96,0.47,cytochrome P450 family 2 subfamily C member 9,1.1489e-20,Abnormality of the cardiovascular system (01626),,14,301,0,4,371,0,"R-HSA-1430728,R-HSA-9748784","Metabolism,Drug ADME",,0.7,Disease or Syndrome (T047),disease,"S5RV20,P11712",C0020538,ENSG00000138109,1559,protein-coding,1,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8461538461538461,,2006.0,CYBB,0.91,0.45,cytochrome b-245 beta chain,,Abnormality of the cardiovascular system (01626),2020.0,18,301,6,196,371,0,"R-HSA-162582,R-HSA-168256,R-HSA-8953897","Signal Transduction,Immune System,Cellular responses to stimuli",Ion channel,0.7,Disease or Syndrome (T047),disease,"A0A0S2Z3S6,P04839",C0020538,ENSG00000165168,1536,protein-coding,0,2,2
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,1997.0,OXT,0.96,0.41,oxytocin/neurophysin I prepropeptide,1.9937e-06,Abnormality of the cardiovascular system (01626),2008.0,37,301,2,1,371,0,R-HSA-162582,Signal Transduction,Signaling,0.7,Disease or Syndrome (T047),disease,"P01178,X5D7M6",C0020538,ENSG00000101405,5020,protein-coding,0,1,2
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.75,,2010.0,CYP1A1,0.96,0.4,cytochrome P450 family 1 subfamily A member 1,8.9759e-18,Abnormality of the cardiovascular system (01626),2012.0,91,301,2,2,371,0,R-HSA-1430728,Metabolism,Enzyme,0.7,Disease or Syndrome (T047),disease,"P04798,A0N0X8,E7EMT5",C0020538,ENSG00000140465,1543,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2006.0,GJA1,0.96,0.38,gap junction protein alpha 1,0.96349,Abnormality of the cardiovascular system (01626),2023.0,50,301,2,145,371,0,"R-HSA-162582,R-HSA-1643685,R-HSA-5653656","Signal Transduction,Disease,Vesicle-mediated transport",Cell-cell junction,0.7,Disease or Syndrome (T047),disease,"P17302,A0A654IBU3",C0020538,ENSG00000152661,2697,protein-coding,0,2,2
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8,,2012.0,SLC6A2,0.96,0.51,solute carrier family 6 member 2,0.89793,Abnormality of the cardiovascular system (01626),2012.0,14,301,1,10,371,0,"R-HSA-1643685,R-HSA-382551","Disease,Transport of small molecules",Transporter,0.7,Disease or Syndrome (T047),disease,P23975,C0020538,ENSG00000103546,6530,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8,,2011.0,GPX1,0.91,0.42,glutathione peroxidase 1,0.0019011,Abnormality of the cardiovascular system (01626),2011.0,76,301,1,1,371,0,"R-HSA-1430728,R-HSA-8953897","Metabolism,Cellular responses to stimuli",Enzyme,0.7,Disease or Syndrome (T047),disease,"Q7L4Q3,P07203,A0A2R8Y6B6",C0020538,ENSG00000233276,2876,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2008.0,CLCNKA,0.61,0.59,chloride voltage-gated channel Ka,1.2127e-17,Abnormality of the cardiovascular system (01626),2008.0,8,301,1,12,371,0,R-HSA-382551,Transport of small molecules,Ion channel,0.7,Disease or Syndrome (T047),disease,P51800,C0020538,ENSG00000186510,1187,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.7142857142857143,,2009.0,GJA5,0.83,0.51,gap junction protein alpha 5,0.50173,Abnormality of the cardiovascular system (01626),2009.0,25,301,1,105,371,0,R-HSA-5653656,Vesicle-mediated transport,Cell-cell junction,0.7,Disease or Syndrome (T047),disease,"P36382,X5D2H9",C0020538,ENSG00000265107,2702,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2013.0,JUN,0.96,0.36,"Jun proto-oncogene, AP-1 transcription factor subunit",0.46638,Abnormality of the cardiovascular system (01626),2013.0,30,301,1,0,371,0,"R-HSA-1266738,R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-74160,R-HSA-8953897","Developmental Biology,Signal Transduction,Disease,Immune System,Gene expression (Transcription),Cellular responses to stimuli",Transcription factor,0.7,Disease or Syndrome (T047),disease,P05412,C0020538,ENSG00000177606,3725,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2010.0,UCN,0.78,0.54,urocortin,0.010134,Abnormality of the cardiovascular system (01626),2010.0,7,301,1,17,371,0,"R-HSA-162582,R-HSA-392499","Signal Transduction,Metabolism of proteins",Signaling,0.7,Disease or Syndrome (T047),disease,P55089,C0020538,ENSG00000163794,7349,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2004.0,INPPL1,0.83,0.56,inositol polyphosphate phosphatase like 1,8.0654e-19,Abnormality of the cardiovascular system (01626),2004.0,6,301,1,32,371,0,"R-HSA-1430728,R-HSA-168256","Metabolism,Immune System",,0.7,Disease or Syndrome (T047),disease,O15357,C0020538,ENSG00000165458,3636,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2000.0,GAL,0.96,0.44,galanin and GMAP prepropeptide,0.013691,Abnormality of the cardiovascular system (01626),2000.0,18,301,1,32,371,0,R-HSA-162582,Signal Transduction,,0.7,Disease or Syndrome (T047),disease,P22466,C0020538,ENSG00000069482,51083,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2013.0,PRKCD,0.91,0.45,protein kinase C delta,1.0,Abnormality of the cardiovascular system (01626),2013.0,14,301,1,147,371,0,"R-HSA-109582,R-HSA-162582,R-HSA-168256,R-HSA-5357801,R-HSA-8953854,R-HSA-8953897","Hemostasis,Signal Transduction,Immune System,Programmed Cell Death,Metabolism of RNA,Cellular responses to stimuli",Kinase,0.7,Disease or Syndrome (T047),disease,"B4DFV1,Q05655",C0020538,ENSG00000163932,5580,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8888888888888888,,2007.0,KCNMB1,0.35,0.73,potassium calcium-activated channel subfamily M regulatory beta subunit 1,5.0452e-08,Abnormality of the cardiovascular system (01626),2007.0,3,301,1,2,371,0,"R-HSA-109582,R-HSA-112316,R-HSA-9709957","Hemostasis,Neuronal System,Sensory Perception",Ion channel,0.7,Disease or Syndrome (T047),disease,Q16558,C0020538,ENSG00000145936,3779,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2008.0,CBS,0.96,0.43,cystathionine beta-synthase,,Abnormality of the cardiovascular system (01626),2008.0,30,301,1,375,371,0,R-HSA-1430728,Metabolism,Enzyme,0.7,Disease or Syndrome (T047),disease,"Q9NTF0,B7Z2D6,P35520",C0020538,ENSG00000160200,875,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2007.0,SLC12A2,0.87,0.52,solute carrier family 12 member 2,0.0038975,Abnormality of the cardiovascular system (01626),2007.0,22,301,1,33,371,0,R-HSA-382551,Transport of small molecules,Transporter,0.7,Disease or Syndrome (T047),disease,"Q53ZR1,B7ZM24,P55011",C0020538,ENSG00000064651,6558,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,NHERF2,0.91,0.44,NHERF family PDZ scaffold protein 2,2.9956e-13,Abnormality of the cardiovascular system (01626),2012.0,1,301,1,4,371,0,,,,0.7,Disease or Syndrome (T047),disease,Q15599,C0020538,ENSG00000065054,9351,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,1983.0,TRH,0.87,0.46,thyrotropin releasing hormone,0.0013787,Abnormality of the cardiovascular system (01626),1983.0,30,301,1,1,371,0,R-HSA-162582,Signal Transduction,,0.7,Disease or Syndrome (T047),disease,P20396,C0020538,ENSG00000170893,7200,protein-coding,0,2,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.75,,2008.0,GUCY1A1,0.7,0.61,guanylate cyclase 1 soluble subunit alpha 1,7.6507e-08,Abnormality of the cardiovascular system (01626),2008.0,18,301,1,25,371,1,"R-HSA-109582,R-HSA-397014","Hemostasis,Muscle contraction",,0.7,Disease or Syndrome (T047),disease,"B3KU69,Q02108",C0020538,ENSG00000164116,2982,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8,,,PKD2,0.87,0.5,"polycystin 2, transient receptor potential cation channel",0.00018492,Abnormality of the cardiovascular system (01626),,26,301,0,369,371,1,R-HSA-1852241,Organelle biogenesis and maintenance,Ion channel,0.7,Disease or Syndrome (T047),disease,"Q13563,Q9UEU6",C0020538,ENSG00000118762,5311,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.6,,,EDN2,0.65,0.62,endothelin 2,,Abnormality of the cardiovascular system (01626),,3,301,0,0,371,0,R-HSA-162582,Signal Transduction,Signaling,0.7,Disease or Syndrome (T047),disease,P20800,C0020538,ENSG00000127129,1907,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,CCR5,0.91,0.4,C-C motif chemokine receptor 5,0.18153,Abnormality of the cardiovascular system (01626),,49,301,0,7,371,0,"R-HSA-162582,R-HSA-1643685,R-HSA-168256","Signal Transduction,Disease,Immune System",G-protein coupled receptor,0.7,Disease or Syndrome (T047),disease,"P51681,Q38L21",C0020538,ENSG00000160791,1234,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.7,,,PNMT,0.78,0.61,phenylethanolamine N-methyltransferase,9.0249e-09,Abnormality of the cardiovascular system (01626),,3,301,0,41,371,0,R-HSA-1430728,Metabolism,Enzyme,0.7,Disease or Syndrome (T047),disease,"A8MT87,P11086",C0020538,ENSG00000141744,5409,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.7142857142857143,,,AVPR1A,0.78,0.58,arginine vasopressin receptor 1A,1.2533e-10,Abnormality of the cardiovascular system (01626),,5,301,0,0,371,0,"R-HSA-162582,R-HSA-1643685","Signal Transduction,Disease",G-protein coupled receptor,0.7,Disease or Syndrome (T047),disease,"X5D2B0,P37288",C0020538,ENSG00000166148,552,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,HTRA1,0.91,0.47,HtrA serine peptidase 1,0.00030454,Abnormality of the cardiovascular system (01626),,27,301,0,83,371,0,R-HSA-1474244,Extracellular matrix organization,Enzyme,0.7,Disease or Syndrome (T047),disease,Q92743,C0020538,ENSG00000166033,5654,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.6666666666666666,,,PTK2B,0.91,0.42,protein tyrosine kinase 2 beta,4.2332e-05,Abnormality of the cardiovascular system (01626),,8,301,0,14,371,0,"R-HSA-1500931,R-HSA-162582,R-HSA-168256","Cell-Cell communication,Signal Transduction,Immune System",Kinase,0.7,Disease or Syndrome (T047),disease,Q14289,C0020538,ENSG00000120899,2185,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8571428571428571,,,DDAH1,0.78,0.58,dimethylarginine dimethylaminohydrolase 1,0.00045963,Abnormality of the cardiovascular system (01626),,7,301,0,16,371,0,R-HSA-1430728,Metabolism,Enzyme,0.7,Disease or Syndrome (T047),disease,"B4E3V1,B2R644,O94760,B4DYP1,B4DGT0",C0020538,ENSG00000153904,23576,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.875,,,BDKRB1,0.87,0.55,bradykinin receptor B1,0.19031,Abnormality of the cardiovascular system (01626),,9,301,0,0,371,0,R-HSA-162582,Signal Transduction,G-protein coupled receptor,0.7,Disease or Syndrome (T047),disease,P46663,C0020538,ENSG00000100739,623,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.0,,,AGXT2,0.61,0.65,alanine--glyoxylate aminotransferase 2,1.3242e-18,Abnormality of the cardiovascular system (01626),,13,301,0,3,371,0,R-HSA-1430728,Metabolism,,0.7,Disease or Syndrome (T047),disease,Q9BYV1,C0020538,ENSG00000113492,64902,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,CACNB2,0.7,0.59,calcium voltage-gated channel auxiliary subunit beta 2,8.8065e-06,Abnormality of the cardiovascular system (01626),,19,301,0,276,371,2,"R-HSA-112316,R-HSA-1266738,R-HSA-1430728,R-HSA-397014,R-HSA-9709957","Neuronal System,Developmental Biology,Metabolism,Muscle contraction,Sensory Perception",Ion channel,0.7,Disease or Syndrome (T047),disease,"Q5VVH1,Q59H42,A0A494C184,Q08289",C0020538,ENSG00000165995,783,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.3333333333333333,,,IL1RN,0.96,0.35,interleukin 1 receptor antagonist,0.0055013,Abnormality of the cardiovascular system (01626),,131,301,0,96,371,0,R-HSA-168256,Immune System,,0.7,Disease or Syndrome (T047),disease,P18510,C0020538,ENSG00000136689,3557,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8333333333333334,,,ADRA1A,0.91,0.56,adrenoceptor alpha 1A,3.5799e-11,Abnormality of the cardiovascular system (01626),,15,301,0,1,371,0,R-HSA-162582,Signal Transduction,G-protein coupled receptor,0.7,Disease or Syndrome (T047),disease,"B0ZBD3,P35348",C0020538,ENSG00000120907,148,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.7142857142857143,,,UCP1,0.83,0.53,uncoupling protein 1,9.1495e-10,Abnormality of the cardiovascular system (01626),,6,301,0,0,371,0,"R-HSA-1266738,R-HSA-1430728","Developmental Biology,Metabolism",Transporter,0.7,Disease or Syndrome (T047),disease,"P25874,Q4KMT7",C0020538,ENSG00000109424,7350,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,CYP2J2,0.78,0.58,cytochrome P450 family 2 subfamily J member 2,4.4525e-12,Abnormality of the cardiovascular system (01626),,7,301,0,2,371,0,R-HSA-1430728,Metabolism,,0.7,Disease or Syndrome (T047),disease,P51589,C0020538,ENSG00000134716,1573,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,MOV10,0.61,0.7,Mov10 RNA helicase,0.99994,Abnormality of the cardiovascular system (01626),,2,301,0,8,371,2,"R-HSA-1266738,R-HSA-1500931,R-HSA-162582,R-HSA-1643685,R-HSA-74160,R-HSA-8953897","Developmental Biology,Cell-Cell communication,Signal Transduction,Disease,Gene expression (Transcription),Cellular responses to stimuli",Enzyme,0.7,Disease or Syndrome (T047),disease,"Q5JR04,Q9HCE1",C0020538,ENSG00000155363,4343,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8333333333333334,,,F11R,0.91,0.53,F11 receptor,1.855e-06,Abnormality of the cardiovascular system (01626),,1,301,0,0,371,0,"R-HSA-109582,R-HSA-1474244,R-HSA-1500931,R-HSA-162582","Hemostasis,Extracellular matrix organization,Cell-Cell communication,Signal Transduction",,0.7,Disease or Syndrome (T047),disease,"Q6FIB4,Q9Y624",C0020538,ENSG00000158769,50848,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.75,,,GPX3,0.91,0.45,glutathione peroxidase 3,1.0819e-08,Abnormality of the cardiovascular system (01626),,34,301,0,1,371,0,R-HSA-8953897,Cellular responses to stimuli,Enzyme,0.7,Disease or Syndrome (T047),disease,P22352,C0020538,ENSG00000211445,2878,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2016.0,IKBKB,0.91,0.46,inhibitor of nuclear factor kappa B kinase subunit beta,0.99571,Abnormality of the cardiovascular system (01626),2020.0,25,301,2,114,371,0,"R-HSA-162582,R-HSA-1643685,R-HSA-168256","Signal Transduction,Disease,Immune System",Kinase,0.65,Disease or Syndrome (T047),disease,O14920,C0020538,ENSG00000104365,3551,protein-coding,0,2,2
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.75,,2012.0,ALOX15,0.91,0.47,arachidonate 15-lipoxygenase,7.136699999999999e-21,Abnormality of the cardiovascular system (01626),2012.0,6,301,1,1,371,0,"R-HSA-1430728,R-HSA-168256","Metabolism,Immune System",Enzyme,0.65,Disease or Syndrome (T047),disease,P16050,C0020538,ENSG00000161905,246,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2020.0,FNDC5,0.91,0.43,fibronectin type III domain containing 5,0.11471,Abnormality of the cardiovascular system (01626),2020.0,5,301,1,0,371,0,,,,0.65,Disease or Syndrome (T047),disease,Q8NAU1,C0020538,ENSG00000160097,252995,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2008.0,TGM2,0.91,0.42,transglutaminase 2,1.5051e-13,Abnormality of the cardiovascular system (01626),2008.0,18,301,1,0,371,0,,,Enzyme,0.65,Disease or Syndrome (T047),disease,"B4DIT7,P21980,V9HWG3,B4DTN7",C0020538,ENSG00000198959,7052,protein-coding,0,2,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,1999.0,BCL2,0.91,0.3,BCL2 apoptosis regulator,0.98901,Abnormality of the cardiovascular system (01626),1999.0,80,301,1,19,371,0,"R-HSA-1266738,R-HSA-162582,R-HSA-168256,R-HSA-5357801,R-HSA-8953897","Developmental Biology,Signal Transduction,Immune System,Programmed Cell Death,Cellular responses to stimuli",Signaling,0.65,Disease or Syndrome (T047),disease,"P10415,A0A7I2V3S7",C0020538,ENSG00000171791,596,protein-coding,0,2,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2017.0,PTPN1,0.91,0.47,protein tyrosine phosphatase non-receptor type 1,1.0,Abnormality of the cardiovascular system (01626),2017.0,17,301,1,4,371,0,"R-HSA-109582,R-HSA-162582,R-HSA-168256,R-HSA-74160","Hemostasis,Signal Transduction,Immune System,Gene expression (Transcription)",,0.65,Disease or Syndrome (T047),disease,"A8K3M3,P18031,B4DSN5",C0020538,ENSG00000196396,5770,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.6666666666666666,,2006.0,CCN2,0.91,0.4,cellular communication network factor 2,2.6587e-06,Abnormality of the cardiovascular system (01626),2006.0,23,301,1,0,371,0,R-HSA-74160,Gene expression (Transcription),Signaling,0.65,Disease or Syndrome (T047),disease,"P29279,Q5M8T4",C0020538,ENSG00000118523,1490,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.3333333333333333,,2016.0,CXCR2,0.91,0.43,C-X-C motif chemokine receptor 2,0.24481,Abnormality of the cardiovascular system (01626),2016.0,24,301,1,3,371,0,"R-HSA-162582,R-HSA-168256","Signal Transduction,Immune System",G-protein coupled receptor,0.65,Disease or Syndrome (T047),disease,"P25025,Q53PC4",C0020538,ENSG00000180871,3579,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2003.0,ERAP1,0.91,0.53,endoplasmic reticulum aminopeptidase 1,1.2026e-21,Abnormality of the cardiovascular system (01626),2003.0,6,301,1,42,371,3,R-HSA-168256,Immune System,Enzyme,0.65,Disease or Syndrome (T047),disease,Q9NZ08,C0020538,ENSG00000164307,51752,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,TP53,0.96,0.26,tumor protein p53,0.99795,Abnormality of the cardiovascular system (01626),2012.0,266,301,1,1249,371,0,"R-HSA-109582,R-HSA-1266738,R-HSA-162582,R-HSA-1640170,R-HSA-1643685,R-HSA-168256,R-HSA-392499,R-HSA-5357801,R-HSA-73894,R-HSA-74160,R-HSA-8953897","Hemostasis,Developmental Biology,Signal Transduction,Cell Cycle,Disease,Immune System,Metabolism of proteins,Programmed Cell Death,DNA Repair,Gene expression (Transcription),Cellular responses to stimuli",Transcription factor,0.65,Disease or Syndrome (T047),disease,"K7PPA8,A0A087WT22,Q53GA5,P04637,A0A087X1Q1,A0A087WXZ1,H2EHT1",C0020538,ENSG00000141510,7157,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.75,,2003.0,CMA1,0.96,0.48,chymase 1,6.259e-11,Abnormality of the cardiovascular system (01626),2003.0,7,301,1,0,371,0,"R-HSA-1474244,R-HSA-162582,R-HSA-392499","Extracellular matrix organization,Signal Transduction,Metabolism of proteins",Enzyme,0.65,Disease or Syndrome (T047),disease,"P23946,Q4FEB3",C0020538,ENSG00000092009,1215,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2009.0,STK11,0.91,0.4,serine/threonine kinase 11,0.99991,Abnormality of the cardiovascular system (01626),2009.0,59,301,1,956,371,0,"R-HSA-1430728,R-HSA-162582,R-HSA-74160","Metabolism,Signal Transduction,Gene expression (Transcription)",Kinase,0.65,Disease or Syndrome (T047),disease,"A0A0S2Z4D1,Q15831",C0020538,ENSG00000118046,6794,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,1991.0,RGS5,0.65,0.58,regulator of G protein signaling 5,0.00012722,Abnormality of the cardiovascular system (01626),1991.0,4,301,1,4,371,0,R-HSA-162582,Signal Transduction,Enzyme modulator,0.65,Disease or Syndrome (T047),disease,O15539,C0020538,ENSG00000143248,8490,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2004.0,PTEN,0.91,0.29,phosphatase and tensin homolog,0.048008,Abnormality of the cardiovascular system (01626),2004.0,167,301,1,1251,371,0,"R-HSA-1430728,R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-392499,R-HSA-74160","Metabolism,Signal Transduction,Disease,Immune System,Metabolism of proteins,Gene expression (Transcription)",Enzyme,0.65,Disease or Syndrome (T047),disease,"F6KD01,P60484",C0020538,ENSG00000171862,5728,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2014.0,LTF,0.96,0.4,lactotransferrin,4.0137e-31,Abnormality of the cardiovascular system (01626),2014.0,24,301,1,2,371,0,"R-HSA-1643685,R-HSA-168256,R-HSA-392499","Disease,Immune System,Metabolism of proteins",Enzyme,0.65,Disease or Syndrome (T047),disease,"V9HWI4,P02788,B3KSL2,Q2TUW9,E7ER44",C0020538,ENSG00000012223,4057,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2013.0,ATP1A1,0.78,0.56,ATPase Na+/K+ transporting subunit alpha 1,1.0,Abnormality of the cardiovascular system (01626),2013.0,17,301,1,23,371,0,"R-HSA-1643685,R-HSA-382551,R-HSA-397014","Disease,Transport of small molecules,Muscle contraction",Transporter,0.65,Disease or Syndrome (T047),disease,P05023,C0020538,ENSG00000163399,476,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,CACNA2D1,0.83,0.54,calcium voltage-gated channel auxiliary subunit alpha2delta 1,0.99946,Abnormality of the cardiovascular system (01626),2012.0,18,301,1,123,371,0,R-HSA-112316,Neuronal System,Ion channel,0.65,Disease or Syndrome (T047),disease,"E7ERK3,Q9UIU0,P54289",C0020538,ENSG00000153956,781,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.6666666666666666,,2004.0,SLC6A18,0.48,0.75,solute carrier family 6 member 18,1.294e-17,Abnormality of the cardiovascular system (01626),2004.0,1,301,1,3,371,0,"R-HSA-1643685,R-HSA-382551","Disease,Transport of small molecules",Transporter,0.65,Disease or Syndrome (T047),disease,Q96N87,C0020538,ENSG00000164363,348932,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2000.0,CRHR2,0.87,0.54,corticotropin releasing hormone receptor 2,4.7132e-18,Abnormality of the cardiovascular system (01626),2000.0,13,301,1,1,371,0,"R-HSA-162582,R-HSA-392499","Signal Transduction,Metabolism of proteins",G-protein coupled receptor,0.65,Disease or Syndrome (T047),disease,"A0A090N7T4,Q13324",C0020538,ENSG00000106113,1395,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,1983.0,GNRH1,0.96,0.42,gonadotropin releasing hormone 1,0.33099,Abnormality of the cardiovascular system (01626),1983.0,34,301,1,17,371,0,R-HSA-162582,Signal Transduction,,0.65,Disease or Syndrome (T047),disease,P01148,C0020538,ENSG00000147437,2796,protein-coding,0,2,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2010.0,STIM1,0.91,0.47,stromal interaction molecule 1,0.99481,Abnormality of the cardiovascular system (01626),2010.0,21,301,1,257,371,0,"R-HSA-109582,R-HSA-168256,R-HSA-397014","Hemostasis,Immune System,Muscle contraction",,0.65,Disease or Syndrome (T047),disease,"Q13586,G0XQ39",C0020538,ENSG00000167323,6786,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.6666666666666666,,,HSD3B1,0.65,0.57,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1",0.00012486,Abnormality of the cardiovascular system (01626),,4,301,0,0,371,0,R-HSA-1430728,Metabolism,Enzyme,0.65,Disease or Syndrome (T047),disease,P14060,C0020538,ENSG00000203857,3283,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,MTR,0.91,0.46,5-methyltetrahydrofolate-homocysteine methyltransferase,2.392e-09,Abnormality of the cardiovascular system (01626),,51,301,0,169,371,0,"R-HSA-1430728,R-HSA-162582,R-HSA-1643685","Metabolism,Signal Transduction,Disease",,0.65,Disease or Syndrome (T047),disease,Q99707,C0020538,ENSG00000116984,4548,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,DIO2,0.83,0.56,iodothyronine deiodinase 2,1.3912e-06,Abnormality of the cardiovascular system (01626),,8,301,0,0,371,0,"R-HSA-1266738,R-HSA-1430728","Developmental Biology,Metabolism",,0.65,Disease or Syndrome (T047),disease,"Q92813,A8K845",C0020538,ENSG00000211448,1734,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,ITGA9,0.83,0.58,integrin subunit alpha 9,0.010458,Abnormality of the cardiovascular system (01626),,10,301,0,26,371,0,"R-HSA-1266738,R-HSA-1474244","Developmental Biology,Extracellular matrix organization",,0.65,Disease or Syndrome (T047),disease,"Q8N6H6,Q13797",C0020538,ENSG00000144668,3680,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,TRHR,0.44,0.66,thyrotropin releasing hormone receptor,0.034484,Abnormality of the cardiovascular system (01626),,14,301,0,7,371,0,R-HSA-162582,Signal Transduction,G-protein coupled receptor,0.65,Disease or Syndrome (T047),disease,P34981,C0020538,ENSG00000174417,7201,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.7777777777777778,,,ADRA2B,0.83,0.52,adrenoceptor alpha 2B,8.2996e-07,Abnormality of the cardiovascular system (01626),,13,301,0,7,371,0,"R-HSA-109582,R-HSA-162582","Hemostasis,Signal Transduction",G-protein coupled receptor,0.65,Disease or Syndrome (T047),disease,P18089,C0020538,ENSG00000274286,151,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,CYP2R1,0.87,0.54,cytochrome P450 family 2 subfamily R member 1,2.4652e-12,Abnormality of the cardiovascular system (01626),,17,301,0,22,371,0,"R-HSA-1430728,R-HSA-1643685","Metabolism,Disease",,0.65,Disease or Syndrome (T047),disease,Q6VVX0,C0020538,ENSG00000186104,120227,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8,,,MMP1,0.91,0.37,matrix metallopeptidase 1,1.3477e-15,Abnormality of the cardiovascular system (01626),,62,301,0,1,371,0,"R-HSA-109582,R-HSA-1474244,R-HSA-168256,R-HSA-392499","Hemostasis,Extracellular matrix organization,Immune System,Metabolism of proteins",Enzyme,0.65,Disease or Syndrome (T047),disease,"P03956,B4DN15,Q53G95",C0020538,ENSG00000196611,4312,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.6666666666666666,,,OGG1,0.91,0.45,8-oxoguanine DNA glycosylase,7.2253e-12,Abnormality of the cardiovascular system (01626),,57,301,0,2,371,0,"R-HSA-1643685,R-HSA-73894","Disease,DNA Repair",,0.65,Disease or Syndrome (T047),disease,"E5KPN0,E5KPN1,O15527,E5KPM8,E5KPM5,E5KPM9,E5KPM6,E5KPM7",C0020538,ENSG00000114026,4968,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,XRCC1,0.91,0.42,X-ray repair cross complementing 1,2.1913e-10,Abnormality of the cardiovascular system (01626),,97,301,0,10,371,0,R-HSA-73894,DNA Repair,,0.65,Disease or Syndrome (T047),disease,"B2RCY5,P18887,Q59HH7",C0020538,ENSG00000073050,7515,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,GCK,0.87,0.49,glucokinase,7.6033e-07,Abnormality of the cardiovascular system (01626),,26,301,0,389,371,0,"R-HSA-1266738,R-HSA-1430728,R-HSA-1643685,R-HSA-74160","Developmental Biology,Metabolism,Disease,Gene expression (Transcription)",Kinase,0.65,Disease or Syndrome (T047),disease,"P35557,Q53Y25",C0020538,ENSG00000106633,2645,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.7142857142857143,,,HTR2A,0.91,0.44,5-hydroxytryptamine receptor 2A,0.35656,Abnormality of the cardiovascular system (01626),,43,301,0,3,371,0,R-HSA-162582,Signal Transduction,G-protein coupled receptor,0.65,Disease or Syndrome (T047),disease,P28223,C0020538,ENSG00000102468,3356,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,ANGPT1,0.87,0.42,angiopoietin 1,0.99987,Abnormality of the cardiovascular system (01626),,15,301,0,23,371,0,"R-HSA-109582,R-HSA-162582","Hemostasis,Signal Transduction",Signaling,0.65,Disease or Syndrome (T047),disease,"B4DTQ9,Q15389",C0020538,ENSG00000154188,284,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,SLC8A1,0.83,0.54,solute carrier family 8 member A1,,Abnormality of the cardiovascular system (01626),,5,301,0,26,371,0,"R-HSA-109582,R-HSA-382551,R-HSA-397014","Hemostasis,Transport of small molecules,Muscle contraction",Transporter,0.65,Disease or Syndrome (T047),disease,"P32418,Q4QQH3",C0020538,ENSG00000183023,6546,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,UCN2,0.74,0.63,urocortin 2,0.022388,Abnormality of the cardiovascular system (01626),,4,301,0,34,371,0,R-HSA-162582,Signal Transduction,,0.65,Disease or Syndrome (T047),disease,Q96RP3,C0020538,ENSG00000145040,90226,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,F7,0.91,0.44,coagulation factor VII,,Abnormality of the cardiovascular system (01626),,26,301,0,132,371,0,"R-HSA-109582,R-HSA-392499,R-HSA-400253","Hemostasis,Metabolism of proteins,Circadian Clock",,0.65,Disease or Syndrome (T047),disease,"B4DPM2,F5H8B0,P08709",C0020538,ENSG00000057593,2155,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.75,,,MTTP,0.83,0.47,microsomal triglyceride transfer protein,6.4626e-07,Abnormality of the cardiovascular system (01626),,11,301,0,166,371,0,R-HSA-382551,Transport of small molecules,Transporter,0.65,Disease or Syndrome (T047),disease,"P55157,B7Z7X3",C0020538,ENSG00000138823,4547,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,PTGIS,0.78,0.56,prostaglandin I2 synthase,1.1926e-15,Abnormality of the cardiovascular system (01626),,17,301,0,7,371,0,R-HSA-1430728,Metabolism,,0.65,Disease or Syndrome (T047),disease,Q16647,C0020538,ENSG00000124212,5740,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,1983.0,PPBP,0.91,0.45,pro-platelet basic protein,0.00046363,Abnormality of the cardiovascular system (01626),2004.0,4,301,2,0,371,0,"R-HSA-109582,R-HSA-162582,R-HSA-168256","Hemostasis,Signal Transduction,Immune System",Signaling,0.6,Disease or Syndrome (T047),disease,P02775,C0020538,ENSG00000163736,5473,protein-coding,0,2,2
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,OXSR1,0.52,0.7,oxidative stress responsive kinase 1,0.91335,Abnormality of the cardiovascular system (01626),2012.0,3,301,1,3,371,0,,,Kinase,0.6,Disease or Syndrome (T047),disease,O95747,C0020538,ENSG00000172939,9943,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,GSK3B,0.96,0.38,glycogen synthase kinase 3 beta,0.89836,Abnormality of the cardiovascular system (01626),2012.0,37,301,1,10,371,0,"R-HSA-1266738,R-HSA-162582,R-HSA-1640170,R-HSA-1643685,R-HSA-74160,R-HSA-8953897","Developmental Biology,Signal Transduction,Cell Cycle,Disease,Gene expression (Transcription),Cellular responses to stimuli",Kinase,0.6,Disease or Syndrome (T047),disease,"P49841,Q6FI27",C0020538,ENSG00000082701,2932,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2011.0,VAV3,0.78,0.57,vav guanine nucleotide exchange factor 3,4.0038e-15,Abnormality of the cardiovascular system (01626),2011.0,6,301,1,19,371,0,"R-HSA-109582,R-HSA-1266738,R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-9748784","Hemostasis,Developmental Biology,Signal Transduction,Disease,Immune System,Drug ADME",,0.6,Disease or Syndrome (T047),disease,Q9UKW4,C0020538,ENSG00000134215,10451,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,GP1BA,0.87,0.51,glycoprotein Ib platelet subunit alpha,0.09978,Abnormality of the cardiovascular system (01626),2012.0,18,301,1,53,371,0,"R-HSA-109582,R-HSA-1643685,R-HSA-74160","Hemostasis,Disease,Gene expression (Transcription)",Receptor,0.6,Disease or Syndrome (T047),disease,"L7UYB8,P07359",C0020538,ENSG00000185245,2811,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,AOC3,0.78,0.51,amine oxidase copper containing 3,4.3347e-15,Abnormality of the cardiovascular system (01626),2012.0,5,301,1,0,371,0,R-HSA-1430728,Metabolism,,0.6,Disease or Syndrome (T047),disease,"Q9UEU7,Q16853",C0020538,ENSG00000131471,8639,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.75,,2014.0,GSTP1,0.96,0.37,glutathione S-transferase pi 1,7.9827e-08,Abnormality of the cardiovascular system (01626),2014.0,113,301,1,2,371,0,"R-HSA-1430728,R-HSA-168256,R-HSA-8953897,R-HSA-9748784","Metabolism,Immune System,Cellular responses to stimuli,Drug ADME",,0.6,Disease or Syndrome (T047),disease,"V9HWE9,P09211",C0020538,ENSG00000084207,2950,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2007.0,TRPC3,0.91,0.56,transient receptor potential cation channel subfamily C member 3,3.3008e-09,Abnormality of the cardiovascular system (01626),2007.0,7,301,1,4,371,0,"R-HSA-109582,R-HSA-1266738,R-HSA-162582,R-HSA-382551,R-HSA-74160","Hemostasis,Developmental Biology,Signal Transduction,Transport of small molecules,Gene expression (Transcription)",Ion channel,0.6,Disease or Syndrome (T047),disease,Q13507,C0020538,ENSG00000138741,7222,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2010.0,ALAD,0.83,0.54,aminolevulinate dehydratase,0.096041,Abnormality of the cardiovascular system (01626),2010.0,18,301,1,70,371,0,"R-HSA-1430728,R-HSA-168256","Metabolism,Immune System",Enzyme,0.6,Disease or Syndrome (T047),disease,"P13716,Q6ZMU0,B7Z3I9,A0A140VJL9",C0020538,ENSG00000148218,210,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.8,,2009.0,RELA,0.96,0.4,"RELA proto-oncogene, NF-kB subunit",0.99992,Abnormality of the cardiovascular system (01626),2020.0,49,301,3,8,371,0,"R-HSA-1266738,R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-392499,R-HSA-4839726,R-HSA-74160,R-HSA-8953897","Developmental Biology,Signal Transduction,Disease,Immune System,Metabolism of proteins,Chromatin organization,Gene expression (Transcription),Cellular responses to stimuli",Transcription factor,0.6,Disease or Syndrome (T047),disease,"A0A087X0W8,Q04206",C0020538,ENSG00000173039,5970,protein-coding,0,3,3
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2005.0,ATP1A2,0.87,0.51,ATPase Na+/K+ transporting subunit alpha 2,1.5754e-05,Abnormality of the cardiovascular system (01626),2005.0,23,301,2,378,371,0,"R-HSA-1643685,R-HSA-382551,R-HSA-397014","Disease,Transport of small molecules,Muscle contraction",Transporter,0.6,Disease or Syndrome (T047),disease,"P50993,A0A0S2Z3W6",C0020538,ENSG00000018625,477,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2011.0,CELA2A,0.87,0.58,chymotrypsin like elastase 2A,7.6509e-11,Abnormality of the cardiovascular system (01626),2019.0,6,301,2,10,371,4,R-HSA-1266738,Developmental Biology,Enzyme,0.6,Disease or Syndrome (T047),disease,P08217,C0020538,ENSG00000142615,63036,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,ANXA1,0.96,0.42,annexin A1,4.7246e-08,Abnormality of the cardiovascular system (01626),2012.0,23,301,1,0,371,0,"R-HSA-162582,R-HSA-168256,R-HSA-397014","Signal Transduction,Immune System,Muscle contraction",,0.6,Disease or Syndrome (T047),disease,"Q5TZZ9,P04083",C0020538,ENSG00000135046,301,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,FMO3,0.78,0.59,flavin containing dimethylaniline monoxygenase 3,4.4665e-12,Abnormality of the cardiovascular system (01626),,9,301,0,58,371,0,"R-HSA-1430728,R-HSA-1643685","Metabolism,Disease",Enzyme,0.6,Disease or Syndrome (T047),disease,"B7Z543,Q53FW5,A0A024R8Z4,P31513,B7Z3M2",C0020538,ENSG00000007933,2328,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,COL6A3,0.87,0.5,collagen type VI alpha 3 chain,1.9429e-13,Abnormality of the cardiovascular system (01626),,36,301,0,717,371,1,"R-HSA-1266738,R-HSA-1474244,R-HSA-162582","Developmental Biology,Extracellular matrix organization,Signal Transduction",Receptor,0.6,Disease or Syndrome (T047),disease,"P12111,B7ZW00,D9ZGF2,Q8N4Z1,Q63HQ4",C0020538,ENSG00000163359,1293,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,LIPE,0.91,0.54,"lipase E, hormone sensitive type",2.2526e-17,Abnormality of the cardiovascular system (01626),,7,301,0,6,371,0,R-HSA-1430728,Metabolism,,0.6,Disease or Syndrome (T047),disease,"Q05469,A8K8W7",C0020538,ENSG00000079435,3991,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,NPHP3,0.74,0.57,nephrocystin 3,1.3726999999999998e-21,Abnormality of the cardiovascular system (01626),,20,301,0,472,371,0,R-HSA-1852241,Organelle biogenesis and maintenance,,0.6,Disease or Syndrome (T047),disease,Q7Z494,C0020538,ENSG00000113971,27031,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,CLU,0.91,0.39,clusterin,0.00056844,Abnormality of the cardiovascular system (01626),,29,301,0,11,371,0,"R-HSA-109582,R-HSA-168256","Hemostasis,Immune System",,0.6,Disease or Syndrome (T047),disease,P10909,C0020538,ENSG00000120885,1191,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,1984.0,F11,0.78,0.54,coagulation factor XI,4.2204999999999996e-22,Abnormality of the cardiovascular system (01626),1984.0,10,301,1,235,371,0,"R-HSA-109582,R-HSA-1643685","Hemostasis,Disease",Enzyme,0.55,Disease or Syndrome (T047),disease,P03951,C0020538,ENSG00000088926,2160,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.5,,1984.0,F12,0.78,0.51,coagulation factor XII,2.7896e-26,Abnormality of the cardiovascular system (01626),1984.0,14,301,1,43,371,1,"R-HSA-109582,R-HSA-1643685","Hemostasis,Disease",Enzyme,0.55,Disease or Syndrome (T047),disease,"Q8IZZ5,P00748",C0020538,ENSG00000131187,2161,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,AQP1,0.87,0.45,aquaporin 1 (Colton blood group),0.013487,Abnormality of the cardiovascular system (01626),2012.0,16,301,1,7,371,0,R-HSA-382551,Transport of small molecules,Ion channel,0.55,Disease or Syndrome (T047),disease,"P29972,A0A024RA31",C0020538,ENSG00000240583,358,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2013.0,ATP2B3,0.78,0.58,ATPase plasma membrane Ca2+ transporting 3,,Abnormality of the cardiovascular system (01626),2013.0,21,301,1,19,371,0,"R-HSA-109582,R-HSA-382551,R-HSA-397014","Hemostasis,Transport of small molecules,Muscle contraction",Transporter,0.55,Disease or Syndrome (T047),disease,"A0A994J5M1,Q16720",C0020538,ENSG00000067842,492,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2009.0,GJC1,0.74,0.64,gap junction protein gamma 1,0.99974,Abnormality of the cardiovascular system (01626),2009.0,1,301,1,1,371,0,"R-HSA-112316,R-HSA-5653656","Neuronal System,Vesicle-mediated transport",Cell-cell junction,0.55,Disease or Syndrome (T047),disease,"A0A654IDC0,P36383",C0020538,ENSG00000182963,10052,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2014.0,DUSP5,0.7,0.56,dual specificity phosphatase 5,2.006e-06,Abnormality of the cardiovascular system (01626),2014.0,1,301,1,0,371,0,R-HSA-162582,Signal Transduction,,0.55,Disease or Syndrome (T047),disease,Q16690,C0020538,ENSG00000138166,1847,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,XRCC3,0.91,0.49,X-ray repair cross complementing 3,1.1578e-15,Abnormality of the cardiovascular system (01626),,34,301,0,4,371,0,R-HSA-73894,DNA Repair,,0.55,Disease or Syndrome (T047),disease,"O43542,Q53XC8",C0020538,ENSG00000126215,7517,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,COL4A5,0.91,0.51,collagen type IV alpha 5 chain,,Abnormality of the cardiovascular system (01626),,30,301,0,584,371,1,"R-HSA-1266738,R-HSA-1474244,R-HSA-162582","Developmental Biology,Extracellular matrix organization,Signal Transduction",,0.55,Disease or Syndrome (T047),disease,"Q49AM6,P29400,A7MBN3",C0020538,ENSG00000188153,1287,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,PRKAG2,0.74,0.54,protein kinase AMP-activated non-catalytic subunit gamma 2,0.19274,Abnormality of the cardiovascular system (01626),,19,301,0,399,371,2,"R-HSA-112316,R-HSA-1430728,R-HSA-162582,R-HSA-1852241,R-HSA-5653656,R-HSA-74160,R-HSA-9612973","Neuronal System,Metabolism,Signal Transduction,Organelle biogenesis and maintenance,Vesicle-mediated transport,Gene expression (Transcription),Autophagy",Enzyme modulator,0.55,Disease or Syndrome (T047),disease,"Q9UGJ0,B7Z6X8,E9PGP6,A0A090N8Q6,A0A384MDZ2",C0020538,ENSG00000106617,51422,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,0.0,,,GLCE,0.52,0.69,glucuronic acid epimerase,0.96461,Abnormality of the cardiovascular system (01626),,2,301,0,0,371,0,R-HSA-1430728,Metabolism,,0.55,Disease or Syndrome (T047),disease,O94923,C0020538,ENSG00000138604,26035,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,PRLHR,0.7,0.66,prolactin releasing hormone receptor,0.14405,Abnormality of the cardiovascular system (01626),,1,301,0,0,371,0,R-HSA-162582,Signal Transduction,G-protein coupled receptor,0.55,Disease or Syndrome (T047),disease,"P49683,A5JUU5",C0020538,ENSG00000119973,2834,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,TPM1,0.87,0.5,tropomyosin 1,0.00058647,Abnormality of the cardiovascular system (01626),2012.0,22,301,1,289,371,0,R-HSA-397014,Muscle contraction,Cellular structure,0.5,Disease or Syndrome (T047),disease,"A0A0K0K1I0,D9YZV4,B7Z722,H0YK48,H7BYY1,D9YZV7,D9YZV5,P09493,F5H7S3,O15513",C0020538,ENSG00000140416,7168,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,1983.0,AOC1,0.83,0.55,amine oxidase copper containing 1,2.3395e-20,Abnormality of the cardiovascular system (01626),1983.0,3,301,1,6,371,0,"R-HSA-1430728,R-HSA-168256","Metabolism,Immune System",,0.5,Disease or Syndrome (T047),disease,P19801,C0020538,ENSG00000002726,26,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,ITM2B,0.83,0.58,integral membrane protein 2B,0.57507,Abnormality of the cardiovascular system (01626),2012.0,6,301,1,7,371,0,R-HSA-392499,Metabolism of proteins,,0.5,Disease or Syndrome (T047),disease,"Q9Y287,A0A384MDP7",C0020538,ENSG00000136156,9445,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2006.0,GJA4,0.87,0.58,gap junction protein alpha 4,0.029819,Abnormality of the cardiovascular system (01626),2006.0,10,301,1,1,371,0,R-HSA-5653656,Vesicle-mediated transport,Cell-cell junction,0.5,Disease or Syndrome (T047),disease,P35212,C0020538,ENSG00000187513,2701,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2001.0,COL1A1,0.91,0.4,collagen type I alpha 1 chain,1.0,Abnormality of the cardiovascular system (01626),2001.0,94,301,1,1030,371,0,"R-HSA-109582,R-HSA-1474244,R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-5653656,R-HSA-74160","Hemostasis,Extracellular matrix organization,Signal Transduction,Disease,Immune System,Vesicle-mediated transport,Gene expression (Transcription)",,0.5,Disease or Syndrome (T047),disease,P02452,C0020538,ENSG00000108821,1277,protein-coding,1,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2007.0,TRPC5,0.7,0.61,transient receptor potential cation channel subfamily C member 5,,Abnormality of the cardiovascular system (01626),2007.0,2,301,1,1,371,0,"R-HSA-1266738,R-HSA-382551","Developmental Biology,Transport of small molecules",Ion channel,0.5,Disease or Syndrome (T047),disease,Q9UL62,C0020538,ENSG00000072315,7224,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,PROC,0.91,0.46,"protein C, inactivator of coagulation factors Va and VIIIa",2.1626e-05,Abnormality of the cardiovascular system (01626),2012.0,31,301,1,172,371,0,"R-HSA-109582,R-HSA-392499","Hemostasis,Metabolism of proteins",Enzyme,0.5,Disease or Syndrome (T047),disease,"P04070,B4DPC8",C0020538,ENSG00000115718,5624,protein-coding,1,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2016.0,MYD88,0.91,0.41,MYD88 innate immune signal transduction adaptor,0.042161,Abnormality of the cardiovascular system (01626),2016.0,40,301,1,44,371,0,"R-HSA-162582,R-HSA-1643685,R-HSA-168256","Signal Transduction,Disease,Immune System",Enzyme modulator,0.5,Disease or Syndrome (T047),disease,"Q99836,A0A3B3ITY3,A0A3F2YP85,A0A0A0MSI9",C0020538,ENSG00000172936,4615,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,PTPRD,0.96,0.53,protein tyrosine phosphatase receptor type D,1.0,Abnormality of the cardiovascular system (01626),,14,301,0,113,371,0,R-HSA-112316,Neuronal System,Enzyme,0.5,Disease or Syndrome (T047),disease,"Q3KPI9,Q2HXI4,Q59H90,P23468",C0020538,ENSG00000153707,5789,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,INVS,0.61,0.62,inversin,1.6677999999999999e-21,Abnormality of the cardiovascular system (01626),,5,301,0,316,371,0,,,,0.5,Disease or Syndrome (T047),disease,"Q9Y283,Q2M1I4",C0020538,ENSG00000119509,27130,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2020.0,MYH7,0.91,0.48,myosin heavy chain 7,1.514e-19,Abnormality of the cardiovascular system (01626),2020.0,78,301,1,1842,371,0,,,,0.45,Disease or Syndrome (T047),disease,P12883,C0020538,ENSG00000092054,4625,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2003.0,ADCY5,0.87,0.54,adenylate cyclase 5,1.0,Abnormality of the cardiovascular system (01626),2003.0,28,301,1,78,371,0,"R-HSA-112316,R-HSA-1430728,R-HSA-162582,R-HSA-1643685,R-HSA-382551","Neuronal System,Metabolism,Signal Transduction,Disease,Transport of small molecules",,0.45,Disease or Syndrome (T047),disease,"B7Z2C7,A0A384P5Q5,O95622,B3KWA8",C0020538,ENSG00000173175,111,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,1997.0,HRH3,0.7,0.57,histamine receptor H3,0.00053882,Abnormality of the cardiovascular system (01626),1997.0,4,301,1,0,371,0,R-HSA-162582,Signal Transduction,G-protein coupled receptor,0.45,Disease or Syndrome (T047),disease,Q9Y5N1,C0020538,ENSG00000101180,11255,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2001.0,COL3A1,0.91,0.44,collagen type III alpha 1 chain,1.0,Abnormality of the cardiovascular system (01626),2001.0,46,301,1,1147,371,0,"R-HSA-1266738,R-HSA-1474244,R-HSA-162582,R-HSA-168256,R-HSA-5653656","Developmental Biology,Extracellular matrix organization,Signal Transduction,Immune System,Vesicle-mediated transport",,0.45,Disease or Syndrome (T047),disease,P02461,C0020538,ENSG00000168542,1281,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,,,,INF2,0.83,0.57,inverted formin 2,0.32386,Abnormality of the cardiovascular system (01626),,26,301,0,366,371,1,,,,0.45,Disease or Syndrome (T047),disease,Q27J81,C0020538,ENSG00000203485,64423,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,NQO1,0.91,0.44,NAD(P)H quinone dehydrogenase 1,2.3078e-08,Abnormality of the cardiovascular system (01626),,44,301,0,2,371,0,"R-HSA-1430728,R-HSA-8953897","Metabolism,Cellular responses to stimuli",,0.45,Disease or Syndrome (T047),disease,"B4DLR8,P15559",C0020538,ENSG00000181019,1728,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,RAMP2,0.65,0.65,receptor activity modifying protein 2,0.0074044,Abnormality of the cardiovascular system (01626),,5,301,0,1,371,0,R-HSA-162582,Signal Transduction,Receptor,0.45,Disease or Syndrome (T047),disease,O60895,C0020538,ENSG00000131477,10266,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,,,,GBA1,0.91,0.43,glucosylceramidase beta 1,9.8755e-05,Abnormality of the cardiovascular system (01626),,32,301,0,208,371,1,"R-HSA-1430728,R-HSA-392499","Metabolism,Metabolism of proteins",,0.45,Disease or Syndrome (T047),disease,"P04062,A0A068F658,B7Z6S9",C0020538,ENSG00000177628,2629,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,HLA-DQA1,0.91,0.44,"major histocompatibility complex, class II, DQ alpha 1",0.00063922,Abnormality of the cardiovascular system (01626),,93,301,0,61,371,0,R-HSA-168256,Immune System,Immune response,0.45,Disease or Syndrome (T047),disease,"A0A173ADG5,P01909,Q8MH44",C0020538,ENSG00000196735,3117,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,BMAL2,0.83,0.61,basic helix-loop-helix ARNT like 2,2.0727e-06,Abnormality of the cardiovascular system (01626),,6,301,0,2,371,0,R-HSA-400253,Circadian Clock,Transcription factor,0.45,Disease or Syndrome (T047),disease,Q8WYA1,C0020538,ENSG00000029153,56938,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,ABCC8,0.87,0.48,ATP binding cassette subfamily C member 8,8.7501e-33,Abnormality of the cardiovascular system (01626),,50,301,0,692,371,0,"R-HSA-112316,R-HSA-1430728,R-HSA-1643685","Neuronal System,Metabolism,Disease",Transporter,0.45,Disease or Syndrome (T047),disease,Q09428,C0020538,ENSG00000006071,6833,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,,,,MEN1,0.96,0.42,menin 1,1.0,Abnormality of the cardiovascular system (01626),,49,301,0,910,371,1,"R-HSA-162582,R-HSA-392499,R-HSA-74160","Signal Transduction,Metabolism of proteins,Gene expression (Transcription)",,0.45,Disease or Syndrome (T047),disease,"Q9GZQ5,O00255",C0020538,ENSG00000133895,4221,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,,,,COL4A4,0.7,0.56,collagen type IV alpha 4 chain,3.6356e-10,Abnormality of the cardiovascular system (01626),,28,301,0,605,371,4,"R-HSA-1266738,R-HSA-1474244,R-HSA-162582","Developmental Biology,Extracellular matrix organization,Signal Transduction",,0.45,Disease or Syndrome (T047),disease,P53420,C0020538,ENSG00000081052,1286,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,RASGRP3,0.74,0.66,RAS guanyl releasing protein 3,8.0531e-07,Abnormality of the cardiovascular system (01626),,3,301,0,10,371,0,"R-HSA-162582,R-HSA-168256","Signal Transduction,Immune System",Enzyme modulator,0.45,Disease or Syndrome (T047),disease,Q8IV61,C0020538,ENSG00000152689,25780,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,,KIF6,0.65,0.65,kinesin family member 6,4.0425e-17,Abnormality of the cardiovascular system (01626),,10,301,0,9,371,0,"R-HSA-109582,R-HSA-5653656","Hemostasis,Vesicle-mediated transport",Cellular structure,0.45,Disease or Syndrome (T047),disease,Q6ZMV9,C0020538,ENSG00000164627,221458,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2010.0,IER3,0.87,0.6,immediate early response 3,0.0028573,Abnormality of the cardiovascular system (01626),2010.0,7,301,1,2,371,0,R-HSA-162582,Signal Transduction,,0.4,Disease or Syndrome (T047),disease,"P46695,A0A1U9X7X2",C0020538,ENSG00000137331,8870,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2000.0,MC2R,0.83,0.54,melanocortin 2 receptor,0.000822,Abnormality of the cardiovascular system (01626),2000.0,14,301,1,104,371,0,"R-HSA-162582,R-HSA-1643685","Signal Transduction,Disease",G-protein coupled receptor,0.4,Disease or Syndrome (T047),disease,Q01718,C0020538,ENSG00000185231,4158,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,MDH1,0.91,0.54,malate dehydrogenase 1,0.47213,Abnormality of the cardiovascular system (01626),2012.0,6,301,1,23,371,0,R-HSA-1430728,Metabolism,Enzyme,0.4,Disease or Syndrome (T047),disease,"A0A5K1VW95,P40925,V9HWF2",C0020538,ENSG00000014641,4190,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,NPTN,0.7,0.64,neuroplastin,0.99999,Abnormality of the cardiovascular system (01626),2012.0,4,301,1,2,371,0,R-HSA-112316,Neuronal System,Receptor,0.4,Disease or Syndrome (T047),disease,Q9Y639,C0020538,ENSG00000156642,27020,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2013.0,KSR2,0.61,0.69,kinase suppressor of ras 2,1.0,Abnormality of the cardiovascular system (01626),2013.0,8,301,1,22,371,1,"R-HSA-162582,R-HSA-1643685","Signal Transduction,Disease",Kinase,0.4,Disease or Syndrome (T047),disease,Q6VAB6,C0020538,ENSG00000171435,283455,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,CXCL2,0.83,0.5,C-X-C motif chemokine ligand 2,5.4312e-05,Abnormality of the cardiovascular system (01626),2012.0,22,301,1,0,371,0,"R-HSA-162582,R-HSA-168256","Signal Transduction,Immune System",Signaling,0.4,Disease or Syndrome (T047),disease,P19875,C0020538,ENSG00000081041,2920,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,1986.0,MOXD2P,0.04,1.0,"monooxygenase DBH like 2, pseudogene",,Abnormality of the cardiovascular system (01626),1986.0,1,301,1,0,371,0,,,,0.4,Disease or Syndrome (T047),disease,,C0020538,ENSG00000240268,100289017,pseudo,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,1996.0,HTR2B,0.74,0.56,5-hydroxytryptamine receptor 2B,1.5287e-08,Abnormality of the cardiovascular system (01626),1996.0,10,301,1,1,371,0,R-HSA-162582,Signal Transduction,G-protein coupled receptor,0.4,Disease or Syndrome (T047),disease,P41595,C0020538,ENSG00000135914,3357,protein-coding,0,2,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2010.0,ORAI1,0.87,0.5,ORAI calcium release-activated calcium modulator 1,,Abnormality of the cardiovascular system (01626),2010.0,6,301,1,114,371,0,"R-HSA-109582,R-HSA-168256,R-HSA-397014","Hemostasis,Immune System,Muscle contraction",Ion channel,0.4,Disease or Syndrome (T047),disease,Q96D31,C0020538,ENSG00000276045,84876,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2013.0,RALBP1,0.87,0.54,ralA binding protein 1,0.79507,Abnormality of the cardiovascular system (01626),2013.0,4,301,1,2,371,0,R-HSA-162582,Signal Transduction,Enzyme modulator,0.4,Disease or Syndrome (T047),disease,Q15311,C0020538,ENSG00000017797,10928,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2016.0,REG3G,0.65,0.67,regenerating family member 3 gamma,1.8995e-07,Abnormality of the cardiovascular system (01626),2016.0,1,301,1,0,371,0,R-HSA-168256,Immune System,,0.4,Disease or Syndrome (T047),disease,Q6UW15,C0020538,ENSG00000143954,130120,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,GCLC,0.91,0.49,glutamate-cysteine ligase catalytic subunit,0.99952,Abnormality of the cardiovascular system (01626),2012.0,17,301,1,9,371,0,"R-HSA-1430728,R-HSA-1643685,R-HSA-8953897","Metabolism,Disease,Cellular responses to stimuli",Enzyme,0.4,Disease or Syndrome (T047),disease,"P48506,Q14TF0,E1CEI4",C0020538,ENSG00000001084,2729,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2007.0,ABCC1,0.91,0.44,ATP binding cassette subfamily C member 1 (ABCC1 blood group),1.1516e-06,Abnormality of the cardiovascular system (01626),2007.0,12,301,1,23,371,0,"R-HSA-1430728,R-HSA-382551,R-HSA-8953897,R-HSA-9748784","Metabolism,Transport of small molecules,Cellular responses to stimuli,Drug ADME",Transporter,0.4,Disease or Syndrome (T047),disease,P33527,C0020538,ENSG00000103222,4363,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,FXYD2,0.44,0.71,FXYD domain containing ion transport regulator 2,0.0079207,Abnormality of the cardiovascular system (01626),2012.0,3,301,1,7,371,0,"R-HSA-1643685,R-HSA-382551,R-HSA-397014","Disease,Transport of small molecules,Muscle contraction",Transporter,0.4,Disease or Syndrome (T047),disease,P54710,C0020538,ENSG00000137731,486,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2020.0,GAD1,0.96,0.5,glutamate decarboxylase 1,0.27606,Abnormality of the cardiovascular system (01626),2020.0,31,301,1,92,371,0,"R-HSA-112316,R-HSA-74160","Neuronal System,Gene expression (Transcription)",Enzyme,0.4,Disease or Syndrome (T047),disease,"A0A0S2Z3V5,Q8IVA8,Q99259",C0020538,ENSG00000128683,2571,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2009.0,RPS6KB1,0.91,0.43,ribosomal protein S6 kinase B1,0.99925,Abnormality of the cardiovascular system (01626),2009.0,11,301,1,6,371,0,R-HSA-162582,Signal Transduction,Kinase,0.4,Disease or Syndrome (T047),disease,P23443,C0020538,ENSG00000108443,6198,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2018.0,HRH2,0.83,0.58,histamine receptor H2,0.99368,Abnormality of the cardiovascular system (01626),2018.0,7,301,1,0,371,0,R-HSA-162582,Signal Transduction,G-protein coupled receptor,0.4,Disease or Syndrome (T047),disease,"A0A1B0GTK7,P25021",C0020538,ENSG00000113749,3274,protein-coding,0,3,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,1983.0,LHB,0.61,0.64,luteinizing hormone subunit beta,0.00012708,Abnormality of the cardiovascular system (01626),1983.0,21,301,1,6,371,0,"R-HSA-1430728,R-HSA-162582,R-HSA-392499","Metabolism,Signal Transduction,Metabolism of proteins",Signaling,0.4,Disease or Syndrome (T047),disease,"A0A0F7RQE6,P01229",C0020538,ENSG00000104826,3972,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,GSTA5,0.39,0.78,glutathione S-transferase alpha 5,,Abnormality of the cardiovascular system (01626),2012.0,1,301,1,0,371,0,R-HSA-1430728,Metabolism,,0.4,Disease or Syndrome (T047),disease,Q7RTV2,C0020538,ENSG00000182793,221357,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,1991.0,EDN3,0.83,0.55,endothelin 3,0.38017,Abnormality of the cardiovascular system (01626),1991.0,15,301,1,61,371,0,"R-HSA-1266738,R-HSA-162582","Developmental Biology,Signal Transduction",Signaling,0.4,Disease or Syndrome (T047),disease,"P14138,Q4FAT2",C0020538,ENSG00000124205,1908,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,GSTT2,0.44,0.72,glutathione S-transferase theta 2 (gene/pseudogene),,Abnormality of the cardiovascular system (01626),2012.0,4,301,1,0,371,0,R-HSA-1430728,Metabolism,,0.4,Disease or Syndrome (T047),disease,P0CG29,C0020538,ENSG00000099984,2953,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2012.0,ATOX1,0.52,0.67,antioxidant 1 copper chaperone,0.082163,Abnormality of the cardiovascular system (01626),2012.0,4,301,1,0,371,0,"R-HSA-168256,R-HSA-8953897","Immune System,Cellular responses to stimuli",,0.4,Disease or Syndrome (T047),disease,O00244,C0020538,ENSG00000177556,475,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,1.0,,2020.0,AIF1,0.87,0.5,allograft inflammatory factor 1,1.9746e-07,Abnormality of the cardiovascular system (01626),2020.0,8,301,1,4,371,0,,,Calcium-binding protein,0.4,Disease or Syndrome (T047),disease,"I3WTX1,P55008,Q4V347",C0020538,ENSG00000204472,199,protein-coding,0,1,1
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,,,,MTX2,0.52,0.64,metaxin 2,0.00031335,Abnormality of the cardiovascular system (01626),,12,301,0,7,371,1,"R-HSA-1852241,R-HSA-9609507","Organelle biogenesis and maintenance,Protein localization",,0.4,Disease or Syndrome (T047),disease,O75431,C0020538,ENSG00000128654,10651,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,,,,BRCA1,0.96,0.34,BRCA1 DNA repair associated,1.4282e-34,Abnormality of the cardiovascular system (01626),,83,301,0,5749,371,0,"R-HSA-1474165,R-HSA-1640170,R-HSA-1643685,R-HSA-392499,R-HSA-73894,R-HSA-74160,R-HSA-8953897","Reproduction,Cell Cycle,Disease,Metabolism of proteins,DNA Repair,Gene expression (Transcription),Cellular responses to stimuli",Enzyme,0.4,Disease or Syndrome (T047),disease,"A0A9Y1QQK3,P38398",C0020538,ENSG00000012048,672,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,,,,DARS2,0.78,0.57,"aspartyl-tRNA synthetase 2, mitochondrial",7.8364e-13,Abnormality of the cardiovascular system (01626),,16,301,0,74,371,2,R-HSA-392499,Metabolism of proteins,Enzyme,0.4,Disease or Syndrome (T047),disease,"Q9H9J7,Q6PI48",C0020538,ENSG00000117593,55157,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,,,,FAT1,0.91,0.5,FAT atypical cadherin 1,1.443e-17,Abnormality of the cardiovascular system (01626),,24,301,0,24,371,0,,,,0.4,Disease or Syndrome (T047),disease,Q14517,C0020538,ENSG00000083857,2195,protein-coding,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,,,,PKD1-AS1,0.13,0.83,PKD1 antisense RNA 1,,Abnormality of the cardiovascular system (01626),,8,301,0,240,371,1,,,,0.4,Disease or Syndrome (T047),disease,,C0020538,ENSG00000259933,105371049,ncRNA,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,,,,,0.39,0.72,GBA recombination region,,Abnormality of the cardiovascular system (01626),,28,301,0,0,371,0,,,,0.4,Disease or Syndrome (T047),disease,,C0020538,,106627981,biological-region,0,0,0
disease of anatomical entity (7),High blood pressure,Cardiovascular Diseases,,,,,0.17,0.85,ATAC-STARR-seq lymphoblastoid silent region 15559,,Abnormality of the cardiovascular system (01626),,5,301,0,0,371,0,,,,0.4,Disease or Syndrome (T047),disease,,C0020538,,129992813,biological-region,0,0,0
